# EDGAR Filing Document

**Accession Number:** 0001791703
**File Stem:** 0001213900-26-009575
**Filing Date:** 2026-1
**Character Count:** 203494
**Document Hash:** 8591059aef04d0d7c6b0f9ac428a2b16
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-009575.hdr.sgml**: 20260129

**ACCESSION NUMBER**: 0001213900-26-009575

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20260129

**FILED AS OF DATE**: 20260129

**DATE AS OF CHANGE**: 20260129

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Titan Mining Corp
- **CENTRAL INDEX KEY:** 0001791703
- **STANDARD INDUSTRIAL CLASSIFICATION:** GOLD & SILVER ORES [1040]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42955
- **FILM NUMBER:** 26578912

**BUSINESS ADDRESS:**
- **STREET 1:** SUITE 555 - 999 CANADA PLACE
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 3E1
- **BUSINESS PHONE:** (604) 638-2003

**MAIL ADDRESS:**
- **STREET 1:** SUITE 555 - 999 CANADA PLACE
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V6C 3E1

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER** 

**THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of <u>January 2026</u>**

Commission File Number: **<u>001-42955</u>**

**<u>Titan Mining Corporation</u>**

(Translation of registrant's name into English)

**<u>Suite 555, 999 Canada Place</u>**

**<u>Vancouver, British Columbia, Canada V6C 3E1</u>**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit** |  |
| 99.1 | [Press Release dated January 29, 2026](ea027422001ex99-1_titan.htm) |
| 99.2 | [Equity Distribution Agreement dated January 28, 2026](ea027422001ex99-2_titan.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **Titan Mining Corporation** |
|  | (Registrant) |
| Date: January 29, 2026 | /s/ Tom Ladner |
|  | Tom Ladner |
|  | General Counsel |

---

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Titan Mining Files Base Shelf Prospectus and Establishes ATM Program**

**Gouverneur, NY, January 29, 2026** – Titan Mining Corporation (**TSX:TI, NYSE-A:TII**), ("**Titan**" or the "**Company**") today announced that it has filed a base shelf prospectus in Canada dated January 27, 2026 (the "**Canadian Base Prospectus**") and a registration statement on Form F-10 (File No. 333-292602) (the "**Registration Statement**") in the United States with the U.S. Securities and Exchange Commission (the "**SEC**") under the U.S./Canada Multijurisdictional Disclosure System, providing the Company the flexibility to be able to raise up to US$150 million, from time to time, over a 25-month period, should it choose to do so.

The filing does not mean that Titan is issuing shares today. Rather, it establishes a flexible financing framework that allows the Company to access capital efficiently in the future to support growth initiatives, advance its U.S. graphite strategy and strengthen its balance sheet as market conditions warrant.

As part of this framework, the Company has also established an "at-the-market" equity program (the "**ATM Program**") under its Canadian Base Prospectus and Registration Statement that allows the Company to issue and sell, from time to time through sales agents, at prevailing market prices for up to US$50 million (or the Canadian dollar equivalent) of its common shares (the "**Offered Shares**") from treasury to the public, at the Company's discretion. Any use of the ATM program would be entirely at Titan's discretion, with timing and volume determined based on market conditions, funding needs, and shareholder considerations.

If utilized, proceeds from the ATM program would be used for working capital, growth initiatives, and general corporate purposes.

**Further details of the ATM**

Sales of Offered Shares, if any, under the ATM Program are anticipated to be made in transactions that are deemed to be "at-the-market distributions" as defined in National Instrument 44-102 – Shelf Distributions and "at-the-market offerings" within the meaning of Rule 415 under the U.S. Securities Act of 1933, as amended (the "**U.S. Securities Act**"), including sales made directly on the Toronto Stock Exchange ("**TSX**"), the NYSE American LLC (the "**NYSE American**"), or any other trading market for the Offered Shares in Canada or the United States, at the market prices prevailing or at negotiated prices, or as otherwise agreed upon by one or more of the Agents (as defined herein) and the Company at the time of sale. The volume and timing of sales under the ATM Program, if any, will be determined in the Company's sole discretion, and at the market price prevailing at the time of each sale, and, as a result, sale prices may vary.

Distributions of the Offered Shares through the ATM Program, if any, will be made pursuant to the terms of an equity distribution agreement dated January 28, 2026 (the "**Equity Distribution Agreement**") with a syndicate of sales agents comprised of BMO Capital Markets Corp., BMO Nesbitt Burns Inc., Cantor Fitzgerald & Co., Cantor Fitzgerald Canada Corporation, H.C. Wainwright & Co. LLC and Maxim Group LLC (collectively, the "**Agents**"). The ATM Program will be effective until the issuance and sale of all of the Offered Shares issuable pursuant to the ATM Program, unless terminated prior to such date in accordance with the terms of the Equity Distribution Agreement.

Listing of the Offered Shares sold pursuant to the ATM Program on the TSX and the NYSE American will be subject to fulfilling all applicable listing requirements.

![](ex99-1_001.jpg)

The sale of Offered Shares through the ATM Program is being made pursuant to a prospectus supplement dated January 28, 2026 (the "**Canadian Prospectus Supplement**") to the Company's Canadian Base Prospectus (together with the Canadian Prospectus Supplement, the "**Canadian Prospectus**") filed with the securities commissions in each of the provinces and territories of Canada, and in the United States pursuant to a prospectus supplement dated January 28, 2026 (the "**U.S. Prospectus Supplement**") to the Company's short form base shelf prospectus (collectively with the U.S. Prospectus Supplement, the "**U.S. Prospectus**") contained in the Company's Registration Statement. The Canadian Prospectus, the U.S. Prospectus and the Registration Statement contain important detailed information about the Company and the ATM Program. Prospective investors should read the Canadian Prospectus, the U.S. Prospectus and the Registration Statement, and the other documents the Company has filed for more complete information about the Company and the ATM Program before making an investment decision. Copies of the Canadian Prospectus are available on SEDAR+ at www.sedarplus.ca and copies of the U.S. Prospectus and the Registration Statement are available on EDGAR at www.sec.gov. Copies of the Canadian Prospectus relating to the ATM Program may also be obtained for free from BMO Nesbitt Burns Inc., Attention: The Data Group of Companies 9195 Torbram Road, Brampton, Ontario L6S 6H2 via telephone at 905.791-3151, ext. 4312; and Cantor Fitzgerald Canada Corporation, Attention: Equity Capital Markets, 181 University Avenue, Suite 1500, Toronto, ON, M5H 3M7; by email at: ecmcanada@cantor.com. Copies of the U.S. Prospectus relating to the ATM Program may be obtained for free from BMO Capital Markets Corp., Attention: Equity Syndicate Department 151 W 42nd Street, 32nd Floor New York, New York 10036 via email at bmoprospectus@bmo.com; Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th floor, New York, New York 10022; by email at: prospectus@cantor.com; from H.C. Wainwright & Co., LLC, Attention: Prospectus Department, 430 Park Avenue, New York, NY 10022, via email at HCWprospectus@hcwco.com; and from Maxim Group LLC, Attention: Syndicate Department, or via email at syndicate@maximgrp.com or telephone at (212) 895-3500.

This news release does not constitute an offer to sell or the solicitation of an offer to buy the Offered Shares, nor shall there be any sale of these securities in any province, state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such province, state or jurisdiction.

**About Titan Mining Corporation**

Titan is an Augusta Group company which produces zinc concentrate at its 100%-owned Empire State Mine located in New York state. Titan is also a natural flake graphite producer.

 ****

***Media & Investor Contact***

Irina Kuznetsova

Director, Investor Relations

Phone: (778) 870-7735

Email: info@titanminingcorp.com

 

 

 

***Cautionary Note Regarding Forward-Looking Information***

Certain statements and information contained in this new release constitute "forward-looking statements", and "forward-looking information" within the meaning of applicable securities laws (collectively, "**forward-looking statements**"). These statements appear in a number of places in this news release and include statements regarding our intent, or the beliefs or current expectations of our officers and directors, including the ATM, including expected benefits, timing, use of proceeds, terms, filing of the prospectus supplement and receiving approvals from the NYSE American and TSX. When used in this news release words such as "to be", "will", "planned", "expected", "potential", and similar expressions are intended to identify these forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, undue reliance should not be placed on forward-looking statements since the Company can give no assurance that such expectations will prove to be correct. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to vary materially from those anticipated in such forward-looking statements, including risks relating to cost increases for capital and operating costs; risks of shortages and fluctuating costs of equipment or supplies; risks relating to fluctuations in the price of zinc and graphite; the inherently hazardous nature of mining-related activities; potential effects on our operations of environmental regulations in New York State; risks due to legal proceedings; and risks related to operation of mining projects generally and the risks, uncertainties and other factors identified in the Company's periodic filings with Canadian securities regulators and with the SEC. Such forward-looking statements are based on various assumptions, including assumptions made with regard to our forecasts and expected cash flows; our projected capital and operating costs; our expectations regarding mining and metallurgical recoveries; mine life and production rates; that laws or regulations impacting mining activities will remain consistent; our approved business plans; our mineral resource estimates and results of the preliminary economic assessment; our experience with regulators; political and social support of the mining industry in New York State; our experience and knowledge of the New York State mining industry and our expectations of economic conditions and the price of zinc and graphite; demand for graphite; exploration results; the ability to secure adequate financing (as needed); the Company maintaining its current strategy and objectives; and the Company's ability to achieve its growth objectives. While the Company considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Except as required by applicable law, we assume no obligation to update or to publicly announce the results of any change to any forward-looking statement contained herein to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements. If we update any one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. You should not place undue importance on forward-looking statements and should not rely upon these forward-looking statements as of any other date. All forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.

## Exhibit 99.2

**Exhibit 99.2**

**TITAN MINING CORPORATION**

Common Shares<br> EQUITY DISTRIBUTION AGREEMENT

January 28, 2026

---

| |
|:---|
| BMO Nesbitt Burns Inc.<br> 885 West Georgia Street, Suite 1700<br> Vancouver, British Columbia V6C 3E8 |
| Cantor Fitzgerald Canada Corporation<br> 181 University Avenue, Suite 1500<br> Toronto, Ontario<br> M5H 3M7 Cantor Fitzgerald & Co.<br> 110 East 59<sup>th</sup> Street<br> New York, New York 10022 |
| H.C. Wainwright & Co., LLC<br> 430 Park Avenue<br> New York, New York 10022 Maxim Group LLC<br> 300 Park Avenue, 16<sup>th</sup> Floor<br> New York, New York 10022 |

---

Ladies and Gentlemen:

Titan Mining Corporation, a corporation incorporated under the *Business Corporations Act* (British Columbia) (the "**Company**"), confirms its agreement (this "**Agreement**") with BMO Nesbitt Burns Inc. and Cantor Fitzgerald Canada Corporation (the "**Canadian Agents**") and BMO Capital Markets Corp., Cantor Fitzgerald & Co., H.C. Wainwright & Co., LLC and Maxim Group LLC (the "**U.S. Agents**", and together with the Canadian Agents, the "**Agents**"), with respect to the issuance and sale from time to time by the Company of common shares of the Company (the "**Shares**"; and common shares in the capital of the Company being referred to as, "**Common Shares**"), having an aggregate offering price of up to US$50,000,000 (or the equivalent in Canadian dollars determined using the daily exchange rate posted by the Bank of Canada on the date the Shares are sold) (the "**Maximum Amount**") through or to the Agents, as sales agents, on the terms and subject to the conditions set forth in this Agreement.

The Company has prepared and filed with the securities regulatory authorities (the "**Canadian Qualifying Authorities**") in each of the provinces and territories of Canada (the "**Canadian Qualifying Jurisdictions**") a preliminary short form base shelf prospectus dated January 7, 2026 (the "**Canadian Preliminary Base Prospectus**") and has prepared and filed with the Canadian Qualifying Authorities in the Canadian Qualifying Jurisdictions the Canadian Base Prospectus (as defined herein) in respect of an aggregate of up to US$150,000,000 (or the equivalent thereof in Canadian dollars or other currencies) of Common Shares, debt securities, warrants to purchase other Shelf Securities (as defined herein), subscription receipts to purchase other Shelf Securities (as defined herein), and units comprised of one or more of the other Shelf Securities (collectively, the "**Shelf Securities**") in each case in accordance with Canadian Securities Laws (as defined herein). The British Columbia Securities Commission (the "**Reviewing Authority**") is the principal regulator of the Company under the passport system procedures provided for under Multilateral Instrument 11-102 — *Passport System* and National Policy 11-202 — *Process for Prospectus Reviews in Multiple Jurisdictions* in respect of the Shelf Securities and the offering of the Shares. The Reviewing Authority has issued a receipt evidencing that a receipt has been issued on behalf of itself and the other Canadian Qualifying Authorities, for the Canadian Preliminary Base Prospectus and the Reviewing Authority has issued a receipt evidencing that a receipt has been issued on behalf of itself and the other Canadian Qualifying Authorities for the Canadian Base Prospectus (the "**Receipt**"). The term "**Canadian Base Prospectus**" means the final short form base shelf prospectus dated January 27, 2026 relating to the Shelf Securities, at the time the Reviewing Authority issued the Receipt with respect thereto in accordance with the applicable rules and regulations under such laws, together with applicable published national, multilateral and local policy statements, instruments, notices and blanket orders of the Canadian Qualifying Authorities in each of the Canadian Qualifying Jurisdictions as modified by the Translation Decision (as defined herein) (the "**Canadian Securities Laws**"), including National Instrument 44-101 - *Short Form Prospectus Distributions* ("**NI 44-101**") and National Instrument 44-102 - *Shelf Distributions* ("**NI 44-102**"), and includes all documents incorporated therein by reference and the documents otherwise deemed to be a part thereof or included therein pursuant to Canadian Securities Laws, including, but not limited to, all Designated News Releases (as defined herein). As used herein, a "**Designated News Release**" means a news release disseminated by the Company in respect of previously undisclosed information that, in the Company's determination, constitutes a material fact (as such term is defined in Canadian Securities Laws) and identified by the Company as a "designated news release" in writing on the face page of the version of such news release that is filed by the Company on the System for Electronic Document Analysis and Retrieval ("**SEDAR+**") in Canada. As used herein, "**Canadian Prospectus Supplement**" means the most recent prospectus supplement to the Canadian Base Prospectus relating to the Shares to be filed by the Company with the Canadian Qualifying Authorities on January 28, 2026 (the "**Prospectus Supplement Filing Date**") in accordance with Canadian Securities Laws and all documents incorporated by reference therein, and any representation and warranty that refers to such supplement will become effective upon its filing. As used herein, "**Canadian Prospectus**" means the Canadian Prospectus Supplement (and any additional Canadian prospectus supplement relating to the Shares prepared in accordance with the provisions of this Agreement and filed with the Canadian Qualifying Authorities in accordance with Canadian Securities Laws) together with the Canadian Base Prospectus. The Canadian Prospectus Supplement shall provide that any and all Designated News Releases shall be deemed to be incorporated by reference in the Canadian Base Prospectus. All Designated News Releases shall also be filed with the Commission (as defined herein) on Form 6-K and the Canadian Prospectus Supplement shall provide that such Form 6-K shall be deemed to be incorporated by reference as an exhibit to the Registration Statement (as defined herein). The "**Translation Decision**" means the decision of the Autorite des marches financiers dated December 18, 2025, obtained by the Company granting exemptive relief from the requirement that the Canadian Prospectus and the documents incorporated by reference in the Canadian Prospectus be publicly filed in both the French and English languages. For the purposes of the Canadian Prospectus, the Company is not required to publicly file French versions of the Canadian Prospectus and the documents incorporated by reference therein.

The Company has also prepared and filed with the United States Securities and Exchange Commission (the "**Commission**"), pursuant to the Canada/U.S. Multi-Jurisdictional Disclosure System adopted by the Commission, a registration statement on Form F-10 (File No. 333-292602), covering the registration of the Shelf Securities under the United States Securities Act of 1933, as amended (the "**Act**"), and the rules and regulations of the Commission thereunder (the "**Rules and Regulations**"), and such amendments to such registration statement as may have been permitted or required to the date of this Agreement. Such registration statement, including the Canadian Base Prospectus (with such deletions therefrom and additions thereto as are permitted or required by Form F-10 and the Rules and Regulations and including exhibits to such registration statement), has become effective by the Commission in such form pursuant to Rule 467(a) under the Act. Such registration statement on Form F-10, at any given time, including amendments and supplements thereto to such time, the exhibits and any schedules thereto at such time and the documents incorporated by reference therein at such time, is herein called the "**Registration Statement**." The Canadian Base Prospectus, with such deletions therefrom and additions thereto as are permitted or required by Form F-10 and the Rules and Regulations in the form in which it appeared in the Registration Statement on the date it became effective under the Act is herein called the "**U.S. Base Prospectus**". "**U.S. Prospectus Supplement**" means the Canadian Prospectus Supplement, with such deletions therefrom and additions thereto as are permitted or required by Form F-10 and the Rules and Regulations, relating to the offering of the Shares, to be filed by the Company with the Commission pursuant to General Instruction II. L of Form F-10, and any representation and warranty that refers to such supplement will become effective upon its filing; "**U.S. Prospectus**" means the U.S. Prospectus Supplement (and any additional U.S. Prospectus Supplement relating to the Shares prepared in accordance with the provisions of this Agreement and filed with the Commission in accordance with General Instruction II.L of Form F-10) together with the U.S. Base Prospectus; "**Base Prospectuses**" means, collectively, the Canadian Base Prospectus and the U.S. Base Prospectus; "**Prospectuses**" means, collectively, the Canadian Prospectus and the U.S. Prospectus; "**Prospectus Supplements**" means, collectively, the Canadian Prospectus Supplement and the U.S. Prospectus Supplement.

Any reference herein to the Registration Statement, the Base Prospectuses, the Prospectus Supplements or the Prospectuses or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms "amend," "amendment" or "supplement" with respect to the Registration Statement, the Base Prospectuses, the Prospectus Supplements or the Prospectuses shall be deemed to refer to and include the filing or furnishing of any document with or to the Commission or Canadian Qualifying Authorities, as applicable, on or after the effective date of the Registration Statement or the date of the Base Prospectuses, the Prospectus Supplements or the Prospectuses, as the case may be, and deemed to be incorporated by reference therein. For purposes of this Agreement, all references to the Canadian Base Prospectus, the Canadian Prospectus Supplement and the Canadian Prospectus or any amendment or supplement thereto shall be deemed to include any copy filed with any Canadian Qualifying Jurisdiction pursuant to SEDAR+ and all references to the Registration Statement, the U.S. Base Prospectus, the U.S. Prospectus Supplement and the U.S. Prospectus or any amendment or supplement thereto shall be deemed to include any copy filed with the Commission pursuant to the Electronic Data Gathering Analysis and Retrieval System ("**EDGAR**").

The Company has also previously prepared and filed with the Commission an appointment of agent for service of process upon the Company on Form F-X in conjunction with the filing of the Registration Statement.

All references in this Agreement to financial statements and schedules and other financial information which is "contained," "included" or "stated" in the Registration Statement, the U.S. Base Prospectus or the U.S. Prospectus (or other references of like import) shall be deemed to mean and include all such financial statements and schedules and other financial information which is incorporated by reference in or otherwise deemed by the Rules and Regulations to be a part of or included in the Registration Statement, the U.S. Base Prospectus, or the U.S. Prospectus, as the case may be. All references in this Agreement to financial statements and other financial information which is "described," "contained," "included" or "stated" in the Canadian Base Prospectus or the Canadian Prospectus (or other references of like import) shall be deemed to mean and include all such financial statements and other financial information which is incorporated by reference in or otherwise deemed by Canadian Securities Laws to be a part of or included in the Canadian Prospectus.

The Company confirms its agreement with the Agents as follows:

1. <u>Sale and Delivery of the Shares</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Agency Transactions*. On the basis
 of the representations, warranties and agreements herein contained, but subject to the terms
 and conditions herein set forth, the Company and the Agents agree that the Company may issue
 and sell through the Agents, as sales agents for the Company, the Shares (an "**Agency Transaction**") as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The Company may, from time to time, propose
 to the applicable Agent that the Company has selected such Agent, in its sole discretion,
 to act as its agent in respect of such Agency Transaction and the terms of an Agency Transaction
 by means of a telephone call or other form of written electronic communication (confirmed
 promptly by electronic mail in a form substantially similar to Exhibit A hereto (an "**Agency Transaction Notice** ")) from at least one of the individuals listed as an authorized
 representative of the Company on Schedule 1 hereto (each, an "**Authorized Company Representative** "), such proposal to include, among other parameters permitted in
 accordance with this Agreement: the trading day(s) for the NYSE American LLC (the "**NYSE American**") or the Toronto Stock Exchange (the "**TSX**") (which
 may not be a day on which the NYSE American or the TSX, as applicable, is closed or scheduled
 to close prior to its regular weekday closing time) on which the Shares are to be sold (each,
 a "**Trading Day** "); the maximum number or value of Shares that the Company
 wishes to sell in the aggregate and on each Trading Day; and the minimum price at which the
 Company is willing to sell the Shares (the "**Floor Price** "). The Agency
 Transaction Notice shall be effective upon delivery to the applicable Agent unless and until
 (A) the applicable Agent declines to accept the terms contained therein and does not confirm
 promptly in accordance with Section 1(a)(ii), (B) the entire amount of the Shares under
 the Agency Transaction Notice have been sold, (C) the Company suspends or terminates the
 Agency Transaction Notice in accordance with the notice requirements set forth in Section 1(a)(vi)
 or Section 8, as applicable, (D) the Company issues a subsequent Agency Transaction
 Notice with parameters superseding those in the earlier Agency Transaction Notice or (E)
 this Agreement has been terminated under the provisions of this Agreement. Notwithstanding
 the foregoing, the Company may not deliver an Agency Transaction Notice to an Agent if the
 Company has delivered an Agency Transaction Notice which remains in effect to another Agent,
 unless the Company has terminated the prior Agency Transaction Notice in accordance with
 the notice requirements set forth in Section 1(a)(vi). The terms of an Agency Transaction
 shall be proposed to, and each Agency Transaction Notice shall be addressed to, the respective
 individuals from the applicable Agent set forth on Schedule 1 hereto (the "**Authorized Agent Representatives** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) If such proposed terms for an Agency Transaction
 are acceptable to the applicable Agent, it shall promptly confirm the terms by countersigning
 the Agency Transaction Notice for such Agency Transaction and emailing it to the Authorized
 Company Representatives which delivered such Agency Transaction Notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Subject to the terms and conditions hereof,
 the applicable Agent shall, severally and not jointly, use its commercially reasonable efforts
 to sell all of the Shares designated in, and subject to the terms of, such Agency Transaction
 Notice. The applicable Agent shall not sell any Share at a price lower than the Floor Price.
 The Company acknowledges and agrees with the Agents that (x) there can be no assurance that
 an Agent will be successful in selling all or any of such Shares or as to the price (at or
 above the Floor Price) at which any Shares are sold, if at all, (y) no Agent shall incur
 liability or obligation to the Company or any other person or entity if they do not sell
 any Shares for any reason; and (z) no Agent shall be required to purchase Shares on a principal
 basis pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Each of the Agents hereby covenants and
 agrees that, during the time an Agent receives an Agency Transaction Notice pursuant to Section
 1(a)(i) hereof that has not been suspended or terminated in accordance with the terms hereof,
 such Agent will prudently and actively monitor the market's reaction to trades made
 on any marketplace (as such term is defined in National Instrument 21-101 - *Marketplace Operation*) pursuant to this Agreement in order to evaluate the likely market impact of
 future trades, and that, if such Agent has concerns as to whether a particular sale contemplated
 by an Agency Transaction Notice may have a significant effect on the market price of the
 Shares, the applicable Agent will, upon receipt of the applicable Agency Transaction Notice,
 recommend to the Company against effecting the trade at that time or on the terms proposed.
 Notwithstanding the foregoing, the Company acknowledges and agrees that the Agents cannot
 provide complete assurances that any sale will not have a significant effect on the market
 price of the Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) The Agents, severally and not jointly, covenant
 that the Agents will not (nor will any affiliate thereof or person or company acting jointly
 or in concert therewith) over-allot Shares in connection with the distribution of Shares
 in an "at-the-market distribution" (as defined in NI 44-102) or "at-the-market"
 (as defined in Rule 415 under the Act) or effect any other transactions that are intended
 to stabilize or maintain the market price of the Shares in connection with such distribution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) The Company may, acting through at least
 one Authorized Company Representative, or the applicable Agent may, upon notice to the other
 party hereto by telephone (confirmed promptly by electronic mail), suspend an offering of
 the Shares or terminate an Agency Transaction Notice; provided, however, that such suspension
 or termination shall not affect or impair the parties' respective obligations with
 respect to the Shares sold hereunder prior to the giving of such notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) If the terms of any Agency Transaction
 as set forth in an Agency Transaction Notice contemplate that the Shares shall be sold on
 more than one Trading Day, then the Company and the applicable Agent shall mutually agree
 to such additional terms and conditions as they deem necessary in respect of such multiple
 Trading Days, and such additional terms and conditions shall be binding to the same extent
 as any other terms contained in the relevant Agency Transaction Notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) The applicable Agent, as sales agent
 in an Agency Transaction, shall not make any sales of the Shares on behalf of the Company,
 pursuant to this Agreement, other than by means of ordinary brokers' transactions (x)
 that qualify for delivery of the Prospectuses in accordance with Rule 153 of the Rules and
 Regulations, (y) that constitute an "at-the-market-distribution" under NI 44-102
 and are made in compliance with NI 44-102 and an "at-the-market" offering under
 Rule 415 under the Act and are made in compliance with Rule 415 under the Act, including,
 without limitation, sales made directly on the NYSE American and the TSX, or any other Canadian
 marketplace or United States marketplace or (z) such other sales of the Shares on behalf
 of the Company in its capacity as agent of the Company as shall be agreed by the Company
 and the applicable Agent in writing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) The cash compensation to the applicable Agent for sales of the Shares
in an Agency Transaction with respect to which such Agent acts as sales agent hereunder (provided that any Agent may decline to participate
in any Agency Transaction in its sole discretion) shall equal 3.0% of the gross offering proceeds of the Shares sold in such Agency Transaction.
The applicable Agent shall provide written confirmation to the Company (which may be provided by email to at least two of the Authorized
Company Representatives) following the close of trading on each Trading Day on which Shares are sold in an Agency Transaction under this
Agreement, setting forth (i) the number and the average price of Shares sold on such Trading Day (showing the number and the average price
of Shares sold on the TSX, on the NYSE American or on any other "marketplace"), (ii) the gross offering proceeds received from
such sales, (iii) the total commission payable by the Company to each Agent with respect to such sales and (iv) the net offering proceeds
(being the gross offering proceeds for such sales less the commission payable for such sales) (the "**Net Offering Proceeds** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) Settlement for sales of the Shares in an
 Agency Transaction pursuant to this Agreement shall occur on the first Trading Day following
 the date on which such sales are made (each such day, a "**Settlement Date** ").
 On each Settlement Date, the Shares sold through the applicable Agent in Agency Transactions
 for settlement on such date shall be issued and delivered by the Company to the applicable
 Agent against payment by the applicable Agent to the Company of the Net Offering Proceeds
 from the sale of such Shares. Settlement for all such Shares shall be effected by free delivery
 of the Shares by the Company or its transfer agent to the applicable Agent's or its
 designee's account (provided that the applicable Agent shall have given the Company
 written notice of such designee prior to the relevant Settlement Date) at The Canadian Depository
 for Securities ()"**CDS** "), The Depository Trust Company ()"**DTC** ")
 or by such other means of delivery as may be mutually agreed upon by the Company and the
 applicable Agent, which in all cases shall be freely tradable, transferable, registered shares
 in good deliverable form, in return for payment in same-day funds delivered to the account
 designated by the Company. If the Company, or its transfer agent (if applicable), shall default
 on its obligation to deliver the Shares on any Settlement Date, the Company shall (i) hold
 the applicable Agent harmless against any loss, claim, damage, or expense (including, without
 limitation, reasonable and documented legal fees and expenses), as incurred, arising out
 of or in connection with such default by the Company and (ii) pay the applicable Agent any
 commission, discount or other compensation to which it would otherwise be entitled absent
 such default; provided, however, that without limiting Section 5 herein, with respect
 to (ii) above, the Company shall not be obligated to pay the applicable Agent any commission,
 discount or other compensation on any Shares that it is not possible to settle due to: (A)
 a suspension or material limitation in trading in securities generally on the TSX or the
 NYSE American; (B) a material disruption in securities settlement or clearance services in
 the United States or Canada; or (C) failure by the applicable Agent to comply with its obligations
 under the terms of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi) The Agents hereby covenant and agree that until June 19,
2026, the Agents will not knowingly sell Shares as part of a negotiated transaction to the Introduced Investors as defined in the Agency
Agreement dated December 16, 2025 between the Company and Maxim Group LLC and as previously disclosed to the Agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Maximum Number of Shares*. Under
 no circumstances shall the Company propose to any one of the Agents, nor will any one of
 the Agents effect, a sale of Shares in an Agency Transaction pursuant to this Agreement if
 such sale would (i) cause the aggregate gross sales proceeds of the Shares sold pursuant
 to this Agreement to exceed the Maximum Amount, (ii) cause the number of Shares sold to exceed
 the number of Common Shares available for offer and sale under the then effective Canadian
 Prospectus or U.S. Prospectus or (iii) cause the number of Shares sold pursuant to this Agreement
 to exceed the number of Shares authorized from time to time to be issued and sold pursuant
 to this Agreement by the Company's board of directors, or a duly authorized committee
 thereof, and notified to the applicable Agent in writing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Regulation M*. If any party hereto
 has reason to believe that the exemptive provisions set forth in Rule 101(c)(1) of Regulation
 M under the United States Securities Exchange Act of 1934, as amended (the "**Exchange Act**") are not satisfied with respect to the Company or the Shares, it shall promptly
 notify the other parties and sales of Shares under this Agreement shall be suspended until
 that or other exemptive provisions have been satisfied in the judgment of each party hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Black-out Periods*. Notwithstanding
 any other provision of this Agreement, no sales of Shares shall take place, the Company shall
 not request the sales of any Shares and the Agents shall not be obligated to sell or offer
 to sell any Shares during any period in which the Company is, or could be deemed to be, in
 possession of material non-public information with respect to the Company. The Company shall
 immediately suspend or revoke any existing Agency Transaction Notice that would otherwise
 request a sale during any such period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Continuing Accuracy of Representations and Warranties*. Any obligation of the Agents to use their commercially reasonable efforts
 to sell the Shares on behalf of the Company as sales agents shall be subject to the continuing
 accuracy of the representations and warranties of the Company herein, to the performance
 by the Company of its obligations hereunder and to the continuing satisfaction of the conditions
 specified in Section 4 of this Agreement.

2. <u>Representations and Warranties of the Company</u>.
 The Company represents and warrants, as of the date hereof, to, and covenants with, the Agents
 as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Corporate Existence and Organization*.
 Each of the Company and the subsidiaries for the Company listed on Schedule 2 to this Agreement
 (the "**Material Subsidiaries**") is a valid and existing company under the
 laws of its jurisdiction of existence and is, with respect to the filing of annual reports
 or the equivalent, in good standing, and has all necessary corporate power and capacity to
 own, lease or license, as the case may be, its properties and assets and carry on its business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Material Subsidiaries*. The Company
 has no subsidiaries that are material other than the Material Subsidiaries and the Company
 is the direct or indirect registered and beneficial owner of all of the issued and outstanding
 shares of the Material Subsidiaries free and clear of any lien, charge, mortgage, pledge,
 security interest, claim, or other encumbrance of any kind whatsoever(each, an "**Encumbrance** "),
 and no person has any agreement, option, right or privilege (whether pre-emptive or contractual)
 capable of becoming an agreement or option, for the purchase from the Company or the Material
 Subsidiaries of any of the shares or other securities of the Material Subsidiaries.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Qualification to Carry on Business*.
 Each of the Company and the Material Subsidiaries is qualified to carry on business in each
 jurisdiction in which it carries on its business, except where the failure to be so qualified
 would not reasonably be expected to: (i) materially adversely affect the condition, financial
 or otherwise, or the earnings, operations, condition, assets, liabilities (absolute, accrued,
 contingent or otherwise), share capital or business affairs of the Company and its Material
 Subsidiaries considered as one enterprise, whether or not arising in the ordinary course
 of business; or (ii) result in the Registration Statement or the Prospectuses containing
 a misrepresentation (each, a "**Material Adverse Effect** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Compliance with Law*. Each of the
 Company and the Material Subsidiaries has complied with, and is not in violation of, any
 applicable laws in the jurisdictions in which it carries on business, including its articles
 and by-laws or other governing documents, other than such non-compliance or violations that
 would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
 Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *No Default or Breach*. The execution
 and delivery of, and the performance of and compliance with the terms of this Agreement by
 the Company and the consummation of any of the transactions contemplated hereby, does not
 and will not result in any breach of, or constitute a default under, and does not and will
 not create a state of facts which, after notice or lapse of time or both, would result in
 a breach of or constitute a default under or create any Encumbrance on its or any of its
 subsidiary's properties or assets under, any term or provision of the articles, by-laws,
 or other governing documents, or resolutions of the Company or any of its subsidiaries, or
 any indenture, mortgage, note, contract, agreement (written or oral), instrument, lease or
 other document to which the Company or any of its subsidiaries is a party or by which it
 or they or any of its or their properties are bound, or any judgment, decree, order, statute,
 rule or regulation applicable to the Company or any of its subsidiaries, which default or
 breach would reasonably be expected to result in a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Corporate Power and Authority*.
 The Company has full corporate power and authority to enter into this Agreement, and to perform
 its obligations set out in this Agreement and this Agreement has been duly authorized, executed
 and delivered by the Company and is a legal, valid and binding obligation of the Company
 enforceable against it in accordance with its terms subject to the general qualifications
 that (i) enforceability may be limited by bankruptcy, insolvency or other laws affecting
 creditors' rights generally, and (ii) equitable remedies, including the remedies of
 specific performance and injunctive relief, are available only in the discretion of the applicable
 court, and (iii) rights of indemnity contained in this Agreement may be limited under applicable
 law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) *Consents and Approvals*. No consent,
approval, authorization, order, permit, license, filing, regulation, clearance or qualification of any court or governmental agency,
body or regulator is required in connection with the transactions contemplated by this Agreement except such as have been obtained or
shall be obtained on or prior to the time of filing of the Prospectus Supplements on the Prospectus Supplement Filing Date under all
of the applicable federal and state securities laws and regulations of the United States, including without limitation the Act, the Exchange
Act and the respective rules and regulations of the Commission thereunder ()"**U.S. Securities Laws** "); Canadian Securities
Laws; the rules of the NYSE American, the TSX or under any other applicable securities laws, and except such customary post-Settlement
Date notice filings, the NYSE American's review and/or approval of the Company's Supplemental Listing Application form, the
TSX's review and final approval of the TSX for the listing of the Shares, and other filings after the date hereof pursuant to applicable
securities laws, including U.S. Securities Laws and Canadian Securities Laws, and stock exchange policies, including the policies of
the TSX and the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) *No Material Adverse Change*. Other
 than as disclosed in the Registration Statement or the Prospectuses, there has not been any
 material adverse change in the capital, assets, condition, liabilities or obligations (absolute,
 accrued, contingent or otherwise) of the Company and its subsidiaries, taken as a whole (a
 "**Material Adverse Change** "), from the position set forth in the latest
 consolidated audited financial statements included or incorporated by reference in the Registration
 Statement and the Prospectuses, including, as applicable, the auditor's reports and
 notes in respect thereof (the "**Annual Financial Statements**") or the latest
 condensed interim consolidated financial statements, including the notes in respect thereof,
 included or incorporated by reference in the Registration Statement and the Prospectuses
 and the Prospectus Supplements (the "**Interim Financial Statements** ", and
 together with the Annual Financial Statements, the "**Financial Statements** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) *Financial Statements*. The Financial
 Statements of the Company, including the related notes thereto, included or incorporated
 by reference in the Registration Statement and the Prospectuses present fairly, in all material
 respects, the financial position of the Company on a consolidated basis as of the dates thereof
 and the results of operations and cash flows of the Company on a consolidated basis for the
 periods indicated, and have been prepared in accordance with IFRS Accounting Standards as
 issued by the International Accounting Standards Board ()"**IFRS**") on a basis
 consistent with prior periods (except as disclosed therein); the Company has no liability or obligation (including, without limitation, liabilities or
 obligations to fund any operations or work or exploration program, to give any guarantees
 or for taxes), whether accrued, absolute, contingent or otherwise, not reflected in such
 Financial Statements, which would be reasonably expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) *Internal Controls.* The Company
 on a consolidated basis maintains a system of internal accounting controls sufficient to
 provide reasonable assurances that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) transactions are executed in accordance
 with management's general or specific authorization;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) transactions are recorded as necessary
 to permit preparation of the Financial Statements in accordance with IFRS and to maintain
 accountability for assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) access to its assets is permitted only
 in accordance with management's general or specific authorization;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) the recorded accountability for assets
 is compared with existing assets at reasonable intervals and appropriate action is taken
 with respect to differences;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) material information relating to the Company
 and the subsidiaries is made known to those within the Company and the subsidiaries, as applicable,
 responsible for the preparation of the Financial Statements during the period in which the
 Financial Statements have been prepared; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) all significant deficiencies and material
 weaknesses in the design or operation of such internal controls that could adversely affect
 the Company's ability to record, process, summarize, and report financial data, in
 accordance with applicable Laws and all fraud, whether or not material, that involves management
 or employees that have a significant role in the Company' internal controls have been
 disclosed to the directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) *Auditor*. Ernst & Young LLP,
 who have audited the Annual Financial Statements and delivered their report included in the
 Annual Financial Statements, have informed the Company that they are independent chartered
 accountants with respect to the Company within the meaning of applicable Canadian Securities
 Laws and independent public accountants within the meaning of U.S. Securities Laws and there
 has not been any "disagreement" or "unresolved issue" (within the
 meaning of National Instrument 51-102 — *Continuous Disclosure Obligations*) with
 Ernst & Young LLP since its initial engagement and any subsequent engagement as the Company's
 auditor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) *No Actions*. There are no actions,
 suits, proceedings or inquiries pending or, to the knowledge of the Company, threatened against
 or affecting the Company or any of its subsidiaries at law or in equity or before or by any
 federal, provincial, state, territorial, municipal or other governmental department, commission,
 board, bureau, agency or instrumentality which would result in a Material Adverse Effect;
 there is no bankruptcy, liquidation, winding-up or other similar proceeding pending or in
 progress, or, to the knowledge of the Company, threatened against or relating to the Company
 or any of its subsidiaries before any governmental authority; none of the Company or any
 of its subsidiaries nor any of the respective properties or assets is subject to any outstanding
 judgment, order, writ, injunction or decree that involves or may involve, or restricts or
 may restrict the right or ability of the Company or such subsidiary to conduct its respective
 business in all material respects as it has been carried on prior to the date hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) *Subsequent Events*. Except as disclosed
 in the Registration Statement and the Prospectuses, since the most recently filed Financial
 Statements, neither the Company nor any of its subsidiaries has incurred, assumed or suffered
 any material liability (absolute, accrued, contingent or otherwise) or entered into any transaction
 which is material to the Company and its subsidiaries, taken as a whole.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) *Public Record*. The information
 and statements set forth in the Registration Statement and the Prospectuses and in all documents
 incorporated by reference in the Registration Statement and the Prospectuses and all information
 filed by or on behalf of the Company with the Canadian Qualifying Authorities, the Commission,
 the TSX, the NYSE American and all applicable self-regulatory authorities after March 19,
 2025, in compliance, or intended compliance, with Canadian Securities Laws (the "**Public Record** "), were, unless otherwise modified by the Registration Statement and Prospectuses
 true, correct and complete in all material respects and did not contain any misrepresentation
 (as defined in the *Securities Act* (British Columbia)), as of the date of such information
 or statements or the date of any amendment to such information or statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) *Reporting Issuer*. The Company is
 a "reporting issuer" or has equivalent status within the meaning of Canadian
 Securities Laws in each of the Canadian Qualifying Jurisdictions and the Company has not
 received any correspondence or notice from any Canadian Qualifying Authority concerning a
 review of any of the Company's continuous disclosure documents in respect of which
 any matters remain outstanding; no delisting, prevention or suspension of trading in or cease
 trading order with respect to any securities of the Company and, to the knowledge of the
 Company, no such proceeding is pending, contemplated or threatened and no inquiry or investigation
 (formal or informal) of any Canadian Qualifying Authority, the Commission, the TSX or the
 NYSE American is in effect or ongoing or, to the knowledge of the Company, expected to be
 implemented or undertaken with respect to the foregoing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) *Exchange Act Compliance*. The Company
 is subject to the reporting requirements of Section 13 of the Exchange Act and has filed
 all periodic reports required under the Exchange Act with the Commission.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q) *Control of Company*. No agreement
 is in force or effect which in any manner affects the voting or control of any of the securities
 of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r) *Taxes*. The Company and each of
 its subsidiaries (A) filed all domestic, foreign, federal, provincial, state and local tax
 returns that are required to be filed or has requested extensions thereof (except in any
 case in which the failure to so file would not result in a Material Adverse Effect) and have
 paid or accrued all taxes required to be paid by it, other than those which are being or
 have been contested in good faith and in respect of which reserves have been provided in
 the Financial Statements of the Company, and any other assessment, fine or penalty levied
 against it, to the extent that any of the foregoing is due and payable, except for any such
 assessment, fine or penalty as would not result in a Material Adverse Effect, (B) duly and
 timely withheld all taxes and other amounts required by applicable laws to be withheld by
 them and have duly and timely remitted to the appropriate governmental authority such taxes
 and other amounts required by applicable laws to be remitted by them except for any such
 taxes and other amounts as would not result in a Material Adverse Effect, and (C) duly and
 timely collected all amounts on account of sales or transfer taxes, including goods and services,
 harmonized sales and provincial or territorial sales taxes, required by applicable laws to
 be collected by them and have duly and timely remitted to the appropriate governmental authority
 any such amounts required by applicable laws to be remitted by them except for any such taxes
 and other amounts as would not result in a Material Adverse Effect; the Company is of the
 opinion that the charges, accruals and reserves for taxes reflected in the Financial Statements
 (whether or not due and whether or not shown on any tax return but excluding any provision
 for deferred income taxes) are adequate under IFRS to cover taxes with respect to the Company
 accruing through the date hereof; there are no disputes, proceedings, investigations, audits,
 assessments, reassessments or claims now pending or to the knowledge of the Company, threatened
 against the Company that propose to assess taxes in addition to those reported in the tax
 returns; there are no liens for taxes upon any of the assets or properties that have not
 been paid by the Company, except for liens for taxes not yet due and payable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s) *Labour Dispute*. No labour problem
 or dispute with the employees of the Company or any of its subsidiaries exists or is threatened
 or to the knowledge of the Company, imminent and the Company is not aware of any existing
 or imminent labour disturbance by the employees of any of its subsidiaries, that would be
 expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t) *Compliance with Employment Laws*.
 Except as would not reasonably be expected, individually or in the aggregate, to have a Material
 Adverse Effect on the Company and its subsidiaries taken as a whole, the Company and its
 subsidiaries are in compliance with all applicable laws respecting employment and labor,
 including employment practices and standards, terms and conditions of employment, wages and
 hours, occupational health and safety, human rights, labor relations, accessibility, and
 workers' compensation. Except as would not reasonably be expected, individually or
 in the aggregate, to have a Material Adverse Effect on the Company and its subsidiaries taken
 as a whole, all employee benefit, pension, executive compensation, incentive compensation,
 stock compensation, retirement, supplementary retirement, health or other medical, dental,
 life or other similar plan, program, agreement or arrangement ()"**Employee Plans** ")
 sponsored, maintained or contributed to or required to be contributed to by the Company or
 its subsidiaries for the benefit of their respective employees and their dependents have
 been established, registered (where required), funded (where required), invested (where required)
 and administered in accordance with, and are in good standing under, all applicable laws,
 the terms of such Employee Plans and all applicable collective agreements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u) *Insurance*. The Company maintains
 policies of insurance that are reasonable, prudent and appropriate for the size and nature
 of the business of the Company, and such policies are in full force and effect as of the
 date hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) *Distributions by Subsidiaries*.
 No subsidiary of the Company is currently prohibited, directly or indirectly, from paying
 any dividends to the Company, from making any other distribution on such subsidiary's capital
 stock or other ownership interest, from repaying to the Company any loans or advances to
 such subsidiary from the Company or from transferring any of such subsidiary's property or
 assets to the Company or any other subsidiary of the Company, except as such restrictions
 or dividends, loans or advances would not reasonably be expected, individually or in the
 aggregate, to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(w) *Disclosure Controls and Procedures*.
 The Company has established disclosure controls and procedures (as defined in Exchange Act
 Rules 13a-15(e)) for the Company and designed such disclosure controls and procedures to
 ensure that information required to be disclosed by the Company in the reports it files or
 submits under the Exchange Act is recorded, processed, summarized and reported, within the
 time periods specified in the Commission's rules and forms. When applicable, the Company's
 certifying officers will evaluate the effectiveness of the Company's disclosure controls
 and procedures as of the end of the period covered by the Company's most recently filed periodic
 report under the Exchange Act (such date, the "**Evaluation Date** "). When applicable,
 the Company will present in its most recently filed periodic report under the Exchange Act
 the conclusions of the certifying officers about the effectiveness of the disclosure controls
 and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
 Date, there will have been no change in the Company's disclosure controls and procedures
 that will materially affect, or will be reasonably likely to materially affect, the Company's
 disclosure controls and procedures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) *Contracts*. All of the material
 contracts and agreements of the Company and its subsidiaries required to be disclosed or
 described in the Registration Statement and the Prospectuses by applicable U.S. Securities
 Laws and Canadian Securities Laws have been disclosed or described in the Registration Statement,
 the Prospectuses or in the Public Record. Neither the Company nor any Material Subsidiary
 has received any notification from any party claiming that the Company or such Material Subsidiary
 is in breach or default under any contract or agreement, except which default or breach would
 not reasonably be expected to result in a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(y) *Licenses and Permits*. Except as
 set forth in the Registration Statement and the Prospectuses, the Company and its subsidiaries
 are the registered owners of and possess, in good standing without default, all licenses,
 sub-licenses, certificates, rights (including, without limitation, surface rights, access
 rights and water rights), permits, concessions, instruments and other authorizations issued
 by, and have made all declarations and filings with, the appropriate federal, provincial,
 state, territorial, local or foreign governmental or regulatory authorities that are necessary
 for the ownership or lease of their respective properties or the conduct of their respective
 businesses as described in each of the Registration Statement and the Prospectuses, including
 for the exploration, exploitation, extraction, removal, processing and refinery of minerals,
 except where the failure to possess, maintain in good standing, or make the same would not
 reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect
 (collectively, "**Permits** "); and except as described in each of the Registration
 Statement and the Prospectuses, neither the Company nor any of its subsidiaries has received
 notice of any revocation, cancellation or modification of, or intention to revoke, cancel
 or modify any such Permit or has any reason to believe that any such Permit will not be renewed
 in the ordinary course, except where such revocation, cancellation or modification would
 not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
 Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(z) *Properties*. Except as disclosed
 in the Registration Statement and the Prospectuses, (i) the Company and each Material Subsidiary
 owns or leases all such properties as are necessary to the conduct of its business as presently
 operated and as proposed to be operated as described in the Registration Statement and the
 Prospectuses; (ii) the Company and the Material Subsidiaries have good and marketable title
 to all real property and good and marketable title to all personal property owned by them,
 in each case free and clear of any and all Encumbrances, except for Encumbrances granted
 in the ordinary course to finance the purchase of personal property, except such as are described
 in the Registration Statement and the Prospectuses or such as do not (individually or in
 the aggregate) materially affect the value of such property or materially interfere with
 the use made or proposed to be made of such property by the Company and the Material Subsidiaries;
 and any material real property and buildings held under lease or sublease by the Company
 and the Material Subsidiaries are held by them under valid, subsisting and enforceable leases
 with such exceptions as are not material to, and do not materially interfere with, the use
 made and proposed to be made of such property and buildings by the Company and the Material
 Subsidiaries; and (iii) neither the Company nor any Material Subsidiary has received any
 notice of any claim adverse to its ownership of any real or personal property or of any claim
 against the continued possession of any real property, whether owned or held under lease
 or sublease by the Company or any Material Subsidiary, except as would not reasonably be
 expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(aa) *Material Property*. The Company's
 Empire State Mines project located in Gouverneur, New York, USA (the "**Empire State Project** "), as described in the Company's technical report entitled "Empire
 State Mines 2025 NI 43-101 Technical Report" with an effective date of December 1,
 2025 and report date of December 15, 2025 (the "**Technical Report** "), the
 Registration Statement and the Prospectus, is the only project which the Company currently
 considers to be "material", and the Company, other than as described in the Registration
 Statement and the Prospectus, is the absolute legal and beneficial owner of, and has good
 and marketable title to, the Empire State Project (the "**Material Property** "),
 and, except as disclosed in the Registration Statement and the Prospectuses, such interests
 are free of all Encumbrances and the Company does not know of any claim or the basis for
 any claim that would reasonably be expected to materially adversely affect the right of the
 Company to use, transfer or otherwise exploit such rights as currently conducted, except
 as disclosed in the Registration Statement and the Prospectuses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(bb) *Mining Claims*. Except as disclosed
 in the Registration Statement and the Prospectuses, all interests in mining claims, concessions,
 exploitation or extraction rights or similar rights comprising the Material Property ()"**Mining Claims**") are in good standing, are valid and enforceable, are free and clear of
 any material Encumbrances, except as could not reasonably be expected to have a Material
 Adverse Effect, and no royalty is payable in respect of any of them, except as disclosed
 in the Registration Statement and the Prospectuses; except as disclosed in the Registration
 Statement and the Prospectuses, there are no material restrictions on the ability of the
 Company and its Material Subsidiaries to use, transfer or otherwise exploit any such property
 rights except as required by applicable law; except as disclosed in the Registration Statement
 and the Prospectuses, the Mining Claims held by the Company or its Material Subsidiaries
 cover the Material Property required by the Company for the purposes described therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(cc) *Compliance with Mining Laws*. (i)
 The Company and its Material Subsidiaries (x) are, and, at all prior times were, in material compliance with any and all applicable laws, rules,
 statutes and regulations relating to exploration, mining and related activities (collectively,
 "**Mining Laws** "), (y) have received and are in compliance with all Permits
 under applicable Mining Laws to conduct their respective businesses, and (z) have not received
 notice of any actual or potential liability under or relating to any Mining Laws and have
 no knowledge of any event or condition that would reasonably be expected to result in any
 such notice; (ii) there are no costs or liabilities associated with Mining Laws of or relating
 to the Company or its Material Subsidiaries, except in the case of each of (i) and (ii) above,
 for any such failure to comply, or failure to receive required permits, licenses or approvals,
 or cost or liability, as would not, individually or in the aggregate, have a Material Adverse
 Effect; and (iii) except as described in each of the Registration Statement and the Prospectuses,
 (x) there are no proceedings, including, but not limited, to orders, rights, directives,
 units or judgments, that are pending, or that are known to be contemplated, against the Company
 or any of its Material Subsidiaries under any Mining Laws in which a governmental entity
 is also a party, except as would not reasonably be expected to have, individually or in the
 aggregate, a Material Adverse Effect, and (y) the Company and its Material Subsidiaries are
 not aware of any noncompliance or potential non-compliance with Mining Laws, or liabilities
 or other obligations under Mining Laws, that would reasonably be expected to have a Material
 Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(dd) *Mineral Resources and Mineral Reserves*.
 Any information relating to estimates by the Company of the mineral resources associated
 with its mineral property projects contained in the Registration Statement and the Prospectuses
 has been prepared in all material respects in accordance with National Instrument 43-101-Standards
 of Disclosure for Mineral Projects ()"**NI 43-101** "); the Company believes
 that all of the assumptions underlying such reserve and resource estimates are reasonable
 and appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ee) *Technical Report and NI 43-101*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The Technical Report was prepared in compliance
 in all material respects with the requirements of NI 43-101;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the Company made available to the authors
 of the Technical Report, prior to the issuance of such report, for the purpose of preparing
 such report, all material information available to the Company and requested by the authors,
 which information to the Company's knowledge did not contain any misrepresentation
 at the time such information was so provided, and, to the knowledge of the Company, there
 have been no material changes to such information since the date of delivery or preparation
 thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) the Company is in material compliance
 with the provisions of NI 43-101 and has filed all technical reports required thereby and
 there has been no change that would require the filing of a new technical report under NI
 43-101; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) all scientific and technical information set forth in the Registration
Statement and the Prospectuses has been reviewed by a "qualified person" as required under NI 43-101 and, to the knowledge of
the Company, has been prepared in accordance in all material respects with Canadian industry standards set forth in NI 43-101 other than
where disclosed in the Registration Statement and the Prospectuses that such information has been prepared under an acceptable foreign
code (as such term is defined in NI 43-101).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ff) *Notice of Adverse Claims*. Neither
 the Company nor the Material Subsidiaries has received any notice of, nor does the Company
 otherwise have any knowledge of, any claim materially adverse to its ownership interests
 in or relating to any Material Property, nor in respect of real property, whether owned or
 held under lease or sublease by the Company or the Material Subsidiaries.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(gg) *No Aboriginal Claims*. There are
 no claims or actions with respect to aboriginal rights currently pending or, to the knowledge
 of the Company, threatened in respect of the properties underlying the Material Property
 that could have a Material Adverse Effect on the Company. The Company is not aware of any
 material land entitlement claims or aboriginal land claims having been asserted or any legal
 actions relating to aboriginal or community issues having been instituted with respect to
 the properties underlying the Material Property, and no material dispute in respect of such
 properties with any local or aboriginal group exists or, to the knowledge of the Company,
 is threatened or imminent with respect thereto or activities thereon.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(hh) *Community Relationships*. There
 are no material complaints, issues, proceedings, or discussions, which are ongoing or anticipated
 which could have the effect of interfering, delaying or impairing the ability to explore,
 develop or operate the Material Property in a manner that would have a material impact on
 the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) *No Work Stoppage or Interruptions*.
 There are no actions, proceedings, inquiries, work or labour disruption, protests, blockades
 or initiatives by nongovernmental organizations, activist groups or similar entities or persons,
 that are ongoing or, to the knowledge of the Company, anticipated which could materially
 adversely affect the ability to explore or develop the operations underlying the Material
 Property in a manner that would have a material impact on the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(jj) *Environmental Matters*. There has
 been no breach of any applicable law, rule, regulation, order, judgment, decree or permit,
 common law provision or other legally binding standard relating to pollution or protection
 of human health and the environment ()"**Environmental Law** "), except for
 breaches which, individually or in the aggregate, would not reasonably be expected to have
 a Material Adverse Effect; there has been no storage, generation, transportation, handling,
 use, treatment, disposal, discharge, emission, contamination or other release of any kind
 at, onto or from any property owned, operated, used or leased by the Company or any subsidiaries
 or into the environment surrounding any such property of any hazardous, toxic or other wastes,
 pollutants, contaminants, petroleum products or other hazardous or toxic substances, chemicals
 or materials ()"**Hazardous Substances**") with respect to which the Company
 or any subsidiary has knowledge, except as would not, individually or in the aggregate, reasonably
 be expected to have a Material Adverse Effect; there is no pending or, to the knowledge of
 the Company, threatened administrative, regulatory or judicial action, claim or notice of
 noncompliance or violation, investigation or proceedings relating to any Environmental Law
 against the Company or any subsidiary, except as would not, individually or in the aggregate,
 reasonably be expected to have a Material Adverse Effect; no property of the Company or any
 subsidiary is subject to the Company's knowledge, to any Encumbrance under any Environmental
 Law; except as disclosed in the Registration Statement and the Prospectuses, neither the
 Company nor any subsidiary is subject to any order, decree, agreement or other individualized
 legal requirement related to any Environmental Law, which, in any case (individually or in
 the aggregate), would reasonably be expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(kk) *Costs and Liabilities related to Compliance with Environmental Laws*. To the knowledge of the Company, costs and liabilities associated
 with Environmental Laws (including, without limitation, any capital or operating expenditures
 required for clean-up, closure or remediation of properties or compliance with Environmental
 Laws, or any permit, license or approval, any related constraints on operating activities
 and any potential liabilities to third parties) would not, subject to maintaining adequate
 reserves for such costs, individually or in the aggregate, reasonably be expected to have
 a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ll) *Expropriation*. No part of the
 property or assets of the Company or its subsidiaries have been taken, condemned or expropriated
 by any governmental authority nor has any written notice or proceeding in respect thereof
 been given or commenced nor does the Company know of any intent or proposal to give such
 notice or commence any such proceedings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(mm) *Books and Records*. The minute
 books of the Company have been maintained in material compliance with all applicable laws
 and are complete and accurate in all material respects, except for minutes of board meetings
 or resolutions of the board of directors that have not been formally approved by the board
 of directors or items in the minute book that are not current, but which are not material
 in the context of the Company and the Material Subsidiaries on a consolidated basis.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(nn) *No Withheld Material Facts*. The
 Company has not withheld from the Agents any material facts known to the Company relating
 to the Company and its subsidiaries as a whole or the offering of Shares hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(oo) *Capitalization*. The Company is
 authorized to issue an unlimited number of Common Shares of which, as at January 26, 2026,
 91,621,438 Common Shares were issued and outstanding, all of which Common Shares are issued
 as fully paid and non-assessable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(pp) *Share Certificate*. The form and
 terms of the certificate representing the Shares has been approved and adopted by the board
 of directors of the Company and the form and terms of the certificate representing the Shares
 does not and will not conflict with any applicable laws or the rules and policies of the
 TSX or the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(qq) *Due and Valid Issuance*. The Shares
 have been duly and validly allotted and reserved for issuance by the Company and when issued
 in accordance with this Agreement, and upon receipt of payment for the Shares, will be, if
 and when issued by the Company, duly and validly issued as fully paid and non-assessable
 Common Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(rr) *No Pre-Emptive Rights*. Except
 as disclosed in the Registration Statement and the Prospectuses, no person currently has
 any agreement, option, right or privilege (whether pre-emptive or contractual) capable of
 becoming an agreement (including convertible securities or warrants but, for greater certainty,
 not including any letter of intent or other non-binding terms outlining a potential transaction
 involving the purchase, subscription or issuance of the Company's securities) for the
 purchase, subscription or issuance of Common Shares or Preferred Shares; no person has the
 right to require the Company or any of its subsidiaries to qualify or register any securities
 for sale under Canadian Securities Laws or the Act by reason of the filing of the Registration
 Statement or the Prospectuses with any Canadian Qualifying Authority or the Commission or
 the issuance and sale of the Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ss) *Securities Law Compliance*. The
 Company is in compliance in all material respects with all its disclosure obligations under
 the Canadian Securities Laws and U.S. Securities Laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(tt) *Stock Exchanges*. The issued and
 outstanding Common Shares are listed and posted for trading on the TSX and the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(uu) *Transfer Agent*. Computershare
 Investor Services Inc. has been duly appointed as transfer agent and registrar for the Common
 Shares in Canada.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vv) *Investment Company*. The Company is not required to be registered as an "investment company"
as defined in the United States Investment Company Act of 1940, as amended, and the rules and regulations of the Commission promulgated
thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ww) *Foreign Private Issuer*. The Company
 is a "foreign private issuer" within the meaning of Rule 405 under the Act; in
 connection with the filing of the Registration Statement, the Company has filed with the
 Commission a Form F-X; the Form F-X conforms with the requirements of the Act and the Rules
 and Regulations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xx) *Sarbanes-Oxley Act*. There is and
 has been no failure on the part of the Company nor, to the knowledge of the Company after
 due enquiry, any of its directors or officers, in their capacities as such, to comply in
 all material respects with any applicable provision of the Sarbanes-Oxley Act of 2002 and
 the rules and regulations promulgated in connection therewith, including, without limitation,
 Section 402 related to loans and Sections 302 and 906 related to certifications.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(yy) *Related Party Transactions*. The
 are no business relationships, contracts, documents, related party transactions or off balance
 sheet transactions or any other non-arm's length transactions involving the Company
 or any subsidiary that are required to be disclosed in, or filed as exhibits to, the Registration
 Statement or the Prospectuses that have not been disclosed or filed in the Registration Statement
 or the Prospectuses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(zz) *Controlled Foreign Corporation*.
 The Company is not currently a "controlled foreign corporation" for U.S. federal
 income tax purposes within the meaning of Section 957 of the United States Internal Revenue
 Code of 1986, as amended, and does not expect to become a controlled foreign corporation
 as a result of the offering of Shares hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(aaa) *Stabilization or Manipulation*.
 The Company has not taken, directly or indirectly, and will not take any action designed
 to or that would constitute or that would reasonably be expected to cause or result in, under
 Canadian Securities Laws or the Act, stabilization or manipulation of the price of any security
 of the Company to facilitate the sale or resale of the Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(bbb) *Significant Acquisition*. The
 Company has not completed any "significant acquisition" (as such term is used
 in NI 44-101) or "restructuring transaction" (as such term is defined in National
 Instrument 51-102 — *Continuous Disclosure Obligations*) that would require the
 inclusion of any additional financial statements or pro forma financial statements in the
 offering documents which such additional financial statements have not already been disclosed
 in the Public Record or the Prospectuses, pursuant to Canadian Securities Laws, and no proposed
 acquisition by the Company has progressed to a state where a reasonable person would believe
 that the likelihood of the Company completing the acquisition is high and that: (i) if completed
 by the Company at the date of the Canadian Prospectus Supplement and U.S. Prospectus Supplement,
 would be a significant acquisition for the purposes of Canadian Securities Laws or (ii) would
 require financial statement disclosure in respect of the acquired business for the purposes
 of Canadian Securities Laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ccc) *Continuous Disclosure*. The Company
 will promptly file all reports required to be filed by it with the Canadian Qualifying Authorities
 under applicable Canadian Securities Laws, and with the Commission pursuant to Section 13(a)
 or 15(d) of the Exchange Act for so long as the delivery of a prospectus relating to the
 Shares is required to be delivered by the Agents under the Act (including in circumstances
 where such requirement may be satisfied pursuant to Rule 153, Rule 172 or Rule 173(a) under
 the Act) or the Canadian Securities Laws, and during such same period will notify the Agents,
 promptly after it receives notice thereof, of the issuance by the Canadian Qualifying Authorities
 or the Commission of any stop order or of any order preventing or suspending the use of any
 prospectus relating to the Shares, of the suspension of the qualification of the Shares for
 offering or sale in any of the Canadian Qualifying Jurisdictions and the United States, of
 the initiation or threat, to the knowledge of the Company, of any proceeding for any such
 purpose, or of any request by the Canadian Qualifying Authorities or the Commission for the
 amending or supplementing of the Registration Statement or the Prospectuses or for additional
 information relating to the Shares; and the Company will use its commercially reasonable
 efforts to prevent the issuance of any such stop order or any such order preventing or suspending
 the use of any prospectus relating to the Shares or the suspension of any such qualification
 and, in the event of the issuance of any such stop order or of any such order preventing
 or suspending the use of any prospectus relating to the Shares or suspending any such qualification,
 to use its commercially reasonable efforts to obtain the withdrawal of such order as soon
 as possible.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ddd) *Filings*. Other than the filing
 of the Canadian Prospectus Supplement, there are no reports or information that in accordance
 with the requirements of Canadian Securities Laws must be made publicly available in connection
 with the offering of the Shares hereby that have not been made publicly available as required;
 and other than the filing of the Canadian Prospectus Supplement there are no documents required
 to be filed with any of the Canadian Qualifying Authorities in connection with the offering
 of Shares hereby that have not been filed as required. The Company has not filed any confidential
 material change or other report or other document with any Canadian Qualifying Authority,
 the Commission, the TSX, the NYSE American, or any other self-regulatory authority which
 at the date hereof remains confidential.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(eee) *Forward-Looking Information and Statements*.
 No forward-looking information (within the meaning of applicable Canadian Securities Laws)
 or forward-looking statements (within the meaning of Section 27A of the Act and Section 21E
 of the Exchange Act) of the Company included or incorporated by reference in the Registration
 Statement or the Prospectuses, has been made or reaffirmed without a reasonable basis or
 has been disclosed other than in good faith, such forward-looking information and forward-looking
 statements are based on assumptions that are reasonable in the circumstances, and the Company
 has updated such forward-looking information and forward-looking statements as required by
 and in compliance with Canadian Securities Laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(fff) *Commissions*. Except for the Agents
 as provided in this Agreement, there is no person acting for the Company entitled to any
 brokerage or finder's fee in connection with this Agreement or any of the transactions
 contemplated hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ggg) *Anti-Bribery Laws*. None of the
 Company, or any of its subsidiaries, directors, officers, or, to the knowledge of the Company,
 any agent, employee, affiliate or other person acting on behalf of the Company or any of
 its subsidiaries, is aware of or has taken any action, directly or indirectly, that would
 result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended,
 and the rules and regulations thereunder (the "**FCPA**") or the *Corruption of Foreign Public Officials Act* (Canada) (the "**CFPOA**") or any other
 applicable anti-bribery or anti-corruption provisions of applicable law, including, without
 limitation, making use of the mails or any means or instrumentality of interstate commerce
 corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment
 of any money, or other property, gift, promise to give, or authorization of the giving of
 anything of value to any "foreign official" (as such term is defined in the FCPA)
 or any foreign political party or official thereof or any candidate for foreign political
 office, in contravention of the FCPA or the CFPOA and the Company and, to the knowledge of
 the Company, its affiliates have conducted their businesses in compliance with the FCPA and
 the CFPOA and have instituted and maintain policies and procedures reasonably designed to
 promote and achieve, and which are reasonably expected to continue to promote and achieve,
 continued compliance therewith.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(hhh) *Money Laundering Laws*. None of
 the Company, or any of its subsidiaries, directors, officers, or, to the knowledge of the
 Company, any of its employees or agents, has at any time (i) made any unlawful contribution
 to any candidate for non-United States office, or failed to disclose fully any such contribution
 in violation of law, or (ii) made any payment to any federal or state governmental officer
 or official, or other person charged with similar public or quasi-public duties, other than
 payments required or permitted by the laws of the United States or any jurisdiction thereof;
 the operations of the Company and each of its subsidiaries are and have been conducted at
 all times in compliance with applicable financial record-keeping and reporting requirements
 of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the *Proceeds of Crime (Money Laundering) and Terrorist Financing Act* (Canada) and the money laundering
 statutes of all other applicable jurisdictions in which the Company or any of its subsidiaries
 does business, the rules and regulations thereunder and any related or similar rules, regulations
 or guidelines issued, administered or enforced by any arbitrator, court, governmental body,
 regulatory body, administrative agency or other authority, body or agency having jurisdiction
 over the Company or any of its subsidiaries or any of their respective properties, assets
 or operations (collectively, the "**Money Laundering Laws** "); and no action,
 suit or proceeding by or before any such arbitrator, court, governmental body, regulatory
 body, administrative agency or other authority body or agency involving the Company or any
 of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge
 of the Company, threatened.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) *Sanctions*. Neither the Company,
 nor any of its subsidiaries, directors, officers, nor, to the knowledge of the Company, any
 agent, employee or representative of the Company or its subsidiaries, affiliate or other
 person associated with or acting on behalf of the Company or its subsidiaries is currently
 subject to or target of any sanctions administered or enforced by the U.S. government (including,
 without limitation, any sanctions administered or enforced by the Office of Foreign Assets
 Control of the U.S. Department of the Treasury, the U.S. Department of State or Bureau of
 Industry and Security of the U.S. Department of Commerce (including, without limitation,
 the designation as a "specially designated national" or "blocked person")),
 Canada (including, without limitation, sanctions administered or enforced by the Office of
 the Superintendent of Financial Institutions), the United Nations Security Council, the European
 Union, His Majesty's Treasury or other relevant sanctions authority (collectively,
 "**Sanctions** "), nor is the Company or any of its subsidiaries located, organized
 or resident in a country or territory that is, or whose government is, the subject or the
 target of Sanctions, including, without limitation, Burma (Myanmar), Cuba, Iran, North Korea,
 Russia, Sudan, Syria, the Crimean region and the non-government controlled areas of Zaporizhzhia
 and Kherson Regions of Ukraine, the so-called Donetsk People's Republic and the so-called
 Luhansk People's Republic (each, a "**Sanctioned Country** "); and
 the Company will not directly or indirectly use the proceeds of the offering of the Shares
 hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary,
 joint venture partner or other person or entity (i) to fund or facilitate any activities
 of or business with any person that, at the time of such funding or facilitation, is the
 subject or the target of Sanctions, (ii) to fund or facilitate any activities of or business
 in any Sanctioned Country, or (iii) in any other manner that will result in a violation by
 any person (including any person participating in the transaction, whether as agent, principal,
 underwriter, advisor, investor or otherwise) of Sanctions. Since December 1, 2020, the Company
 and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and
 will not engage in, any dealings or transactions with any person that at the time of the
 dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned
 Country.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(jjj) *IT Systems*. Except as disclosed
 in the Registration Statement or the Prospectuses, or as would not reasonably be expected
 to have a Material Adverse Effect, (i) there has been no security breach or other compromise
 of or relating to any of the Company's information technology and computer systems,
 networks, hardware, software, data (including the data of their respective customers, employees,
 suppliers, vendors and any third party data maintained by or on behalf of them), equipment
 or technology (collectively, "**IT Systems and Data**") and (ii) the Company
 has not been notified of, and has no knowledge of any event or condition that would reasonably
 be expected to result in, any security breach or other compromise to their IT Systems and
 Data. The Company is presently in compliance with all applicable laws or statutes and all
 judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory
 authority, internal policies and contractual obligations relating to the privacy and security
 of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized
 use, access, misappropriation or modification, except as would not, individually or in the
 aggregate, reasonably be expected to have a Material Adverse Effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(kkk) *Effectiveness of Registration*.
 The Company is qualified in accordance with the provisions of NI 44-101 and NI 44-102 to
 file a short form base shelf prospectus in each of the Canadian Qualifying Jurisdictions
 and the entering into of this Agreement will not cause the Receipt to no longer be effective.
 At the time of filing the Registration Statement, the Company met the
 general eligibility requirements for use of Form F-10 under the Act. Any amendment or supplement
 to the Registration Statement or the Prospectuses required by this Agreement will be so prepared
 and filed by the Company and, as applicable, the Company will use commercially reasonable
 efforts to cause it to become effective as soon as reasonably practicable. The Commission's
 website indicates that no stop order suspending the effectiveness of the Registration Statement
 is in effect. No proceedings for such purpose have been instituted or are pending or, to
 the knowledge of the Company, are contemplated or threatened by the Commission. No order
 preventing or suspending the use of the Prospectuses or any Permitted Free Writing Prospectus
 (as defined herein) has been issued by the Commission or any Canadian Qualifying Authority.
 The Canadian Prospectus, at the time of filing thereof with the Canadian Qualifying Authorities,
 complied in all material respects and, as amended or supplemented, if applicable, will comply
 in all material respects with Canadian Securities Laws. The Canadian Prospectus, as amended
 or supplemented, as of its date, did not and, as of each Time of Sale and Settlement Date,
 if any, will not contain a misrepresentation, as defined under Canadian Securities Laws.
 The Canadian Prospectus, as amended or supplemented, as of its date, did and, as of each
 Time of Sale and Settlement Date, if any, will contain full, true and plain disclosure of
 all material facts relating to the Shares and to the Company. The representations and warranties
 set forth in the two immediately preceding sentences do not apply to statements in or omissions
 from the Canadian Prospectus, or any amendments or supplements thereto, made in reliance
 on and in conformity with information relating to the Agents furnished in writing to the
 Company by or on behalf of the Agents expressly for inclusion therein. The U.S. Prospectus,
 at the time first filed in accordance with General Instruction II.L. of Form F-10, will conform
 in all material respects and, as amended or supplemented, if applicable, will conform in
 all material respects to the Canadian Prospectus, except for such deletions therefrom and
 additions thereto as are permitted or required by Form F-10 and the Rules and Regulations.
 The Company has delivered or made available to the Agents a complete copy of each of the
 Canadian Base Prospectus and the Registration Statement and a copy of each consent of experts
 filed as a part thereof, and conformed copies of the Canadian Base Prospectus, the Registration
 Statement (without exhibits) and the Prospectuses, as amended or supplemented, at such places
 as the Agents have reasonably requested. At the time of filing the Registration Statement
 and at the earliest time after the filing of the Registration Statement that the Company
 or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2)
 under the Act) of the Shares, the Company was not and, as of the date of this Agreement,
 is not, an Ineligible Issuer (as defined in Rule 405 under the Act), without taking account
 of any determination by the Commission pursuant to Rule 405 under the Act that it is not
 necessary that the Company be considered an Ineligible Issuer. "**Time of Sale** "
 means the time of the applicable Agent's initial entry into contracts with investors
 for the sale of such Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(lll) *Accuracy*. Each part of the Registration
 Statement, when such part became or becomes effective, at any deemed effective date pursuant
 to Form F-10 and the Rules and Regulations on the date of filing thereof with the Commission
 and at each Time of Sale and Settlement Date on the date of filing thereof with the Commission
 and at each Time of Sale and Settlement Date, conformed in all material respects, or will
 conform in all material respects with the requirements of the Rules and Regulations; the
 U.S. Prospectus, on the date of filing thereof with the Commission will conform in all material
 respects with the requirements of the Rules and Regulations; each part of the Registration
 Statement, when such part became or becomes effective, did not and will not contain an untrue
 statement of a material fact or omit to state a material fact required to be stated therein
 or necessary to make the statements therein not misleading; and the U.S. Prospectus, on the
 date of filing thereof with the Commission, and the U.S. Prospectus and the applicable Permitted
 Free Writing Prospectus(es), if any, issued at or prior to such Time of Sale, taken together,
 and at each Time of Sale and Settlement Date, will not contain any untrue statement of a
 material fact or omit to state a material fact necessary in order to make the statements
 therein, in the light of the circumstances under which they were made, not misleading; except
 that the foregoing shall not apply to statements in or omissions from any such document made
 in reliance on and in conformity with information relating to the Agents furnished in writing
 to the Company by or on behalf of the Agents expressly for inclusion in the Registration
 Statement, the U.S. Prospectus or any Permitted Free Writing Prospectus, or any amendment
 or supplement thereto.

Any certificate signed by any officer of the Company and delivered to the Agents or to counsel for the Agents shall be deemed a representation and warranty by the Company, as the case may be, to the Agents as to the matters covered thereby.

3. <u>Agreements of the Company</u>. The Company
 covenants and agrees with the Agents as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Prospectus and Registration Statement Amendments*. After the date of this Agreement and until the completion of the sales contemplated
 hereunder, (i) the Company will notify the Agents promptly of the time when any subsequent
 amendment to the Canadian Base Prospectus or the Registration Statement has been filed with
 any Canadian Qualifying Authority or the Commission and has become effective or where a receipt
 has been issued therefor, as applicable, or any subsequent supplement to the U.S. Prospectus
 or the Canadian Prospectus has been filed (each, an "**Amendment Date** ")
 and of any request by the Commission or any Canadian Qualifying Authority for any amendment
 or supplement to the Registration Statement or the Prospectuses or for additional information;
 (ii) the Company will file promptly all other material required to be filed by it with the
 Commission pursuant to Rule 433(d) and with the Canadian Qualifying Authorities; (iii) the
 Company will submit to the Agents a copy of any amendment or supplement to the Registration
 Statement or the Prospectuses (other than a copy of any documents incorporated by reference
 into the Registration Statement or the Prospectuses) within a reasonable period of time before
 the filing thereof and will afford the Agents and the Agents' counsel a reasonable
 opportunity to comment on any such proposed filing prior to such proposed filing; and (iv)
 the Company will furnish to the Agents at the time of filing thereof a copy of any document
 that upon filing is deemed to be incorporated by reference in the Registration Statement
 or the Prospectuses (provided that the Company shall not be required to deliver documents
 or information incorporated by reference into the Registration Statement or the Prospectuses
 if such documents are accessible from SEDAR+ or EDGAR) and the Company will cause (A) each
 amendment or supplement to the U.S. Prospectus to be filed with the Commission as required
 pursuant to General Instruction II.L of Form F-10 of the Rules and Regulations or, in the
 case of any document to be incorporated therein by reference, to be filed with the Commission
 as required pursuant to the Exchange Act, within the time period prescribed and (B) each
 amendment or supplement to the Canadian Prospectus to be filed with the Canadian Qualifying
 Authorities as required pursuant to NI 44-101 and NI 44-102 (the "**Canadian Shelf Procedures**") or, in the case of any document to be incorporated therein by reference,
 to be filed with the Canadian Qualifying Authorities as required pursuant to the Canadian
 Securities Laws, within the time period prescribed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Notice of Stop Orders*. The Company
 will advise the Agents, promptly after it receives notice thereof, of the issuance by the
 Commission or the Canadian Qualifying Authorities of any stop order or of any order preventing
 or suspending the use of the Prospectuses or other prospectus in respect of the Shares, of
 any notice of objection of the Commission to the use of the form of the Registration Statement
 or any post-effective amendment thereto, of the suspension of the qualification of the Shares
 for offering or sale in the United States or the Canadian Qualifying Jurisdictions, of the
 initiation or threatening of any proceeding for any such purpose or of any request by the
 Commission or the Canadian Qualifying Authorities for the amending or supplementing of the
 Registration Statement or the Prospectuses or for additional information relating to the
 Shares. If there is an Agency Transaction Notice that has been issued by the Company that
 has not been suspended or terminated in accordance with the notice requirements set forth
 in Section 1(a)(vi) or Section 8, as applicable, the Company will use its commercially reasonable
 efforts to prevent the issuance of any stop order or any order preventing or suspending the
 use of the Prospectuses or other prospectus in respect of the Shares, a notice of objection
 of the Commission to the form of the Registration Statement or any post-effective amendment
 thereto or the suspension of any qualification for offering or sale in the United States
 or the Canadian Qualifying Jurisdictions, and, in the event of the issuance of any such stop
 order or any such order preventing or suspending the use of any prospectus relating to the
 Shares or suspending any such qualification, the Company will use its commercially reasonable
 efforts to obtain the lifting or withdrawal of such order as soon as possible. If there is
 no such outstanding Agency Transaction Notice, then, if, in the Company's determination
 and at the Company's sole discretion, it is necessary to prevent the issuance of any
 stop order or have a stop order lifted, the Company will use its commercially reasonable
 efforts to prevent the issuance of any stop order or any order preventing or suspending the
 use of the Prospectuses or other prospectus in respect of the Shares, a notice of objection
 of the Commission to the form of the Registration Statement or any post-effective amendment
 thereto or the suspension of any qualification for offering or sale in the United States
 or the Canadian Qualifying Jurisdictions, and, in the event of the issuance of any such stop
 order or any such order preventing or suspending the use of any prospectus relating to the
 Shares or suspending any such qualification, the Company will use its commercially reasonable
 efforts to obtain the lifting or withdrawal of such order as soon as possible.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Delivery of Prospectus; Subsequent Changes*. Within the time during which a prospectus relating to the Shares is required
 to be delivered by the Agents under the Act (including in circumstances where such requirement
 may be satisfied pursuant to Rule 153, Rule 172 or Rule 173(a) under the Act) or the Canadian
 Securities Laws (disregarding, for such purpose, Section 9.2(1) of NI 44-102), the Company
 will comply in all material respects with all requirements imposed upon it by the Act, by
 the Rules and Regulations, as appropriate and as from time to time in force, and will file
 or furnish on or before their respective due dates all reports required to be filed or furnished
 by it with the Commission pursuant to Sections 13(a), 13(c), or 15(d) of the Exchange Act,
 if applicable, or any other applicable provision of or under the Exchange Act or with the
 Canadian Qualifying Authorities pursuant to the Canadian Securities Laws, as appropriate.
 If during such period any event occurs as a result of which the Prospectuses as then amended
 or supplemented would include an untrue statement of material fact or omit to state a material
 fact necessary to make the statements therein, in the light of the circumstances then existing,
 not misleading, or if during such period it is necessary to amend or supplement the Registration
 Statement or the Prospectuses to comply with the Act or the Canadian Securities Laws, the
 Company will promptly notify the Agents to suspend the offering of Shares during such period
 and, if, in the Company's determination and at the Company's sole discretion,
 it is necessary to file an amendment or supplement to the Registration Statement or the Prospectuses
 to comply with the Act or the Canadian Securities Laws, the Company will promptly prepare
 and file with the Canadian Qualifying Authorities and the Commission such amendment or supplement
 as may be necessary to correct such statement or omission or to make the Registration Statement
 or the Prospectuses comply with such requirements, and the Company will furnish to the Agents
 such number of copies of such amendment or supplement as the Agents may reasonably request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Delivery of Registration Statement and Prospectuses*. The Company will furnish to the Agents and their counsel (at the expense
 of the Company) copies of the Registration Statement, the Prospectuses (including all documents
 incorporated by reference therein) and all amendments and supplements to the Registration
 Statement or the Prospectuses to be used in connection with the offering or the sale of Shares
 and that are filed with the Commission and the Canadian Qualifying Authorities during the
 period in which a prospectus relating to the Shares is required to be delivered under Canadian
 Securities Laws or the Act (including all documents filed with the Canadian Qualifying Authorities
 and the Commission during such period that are deemed to be incorporated by reference therein),
 in each case as soon as reasonably practicable and in such quantities as the Agents may from
 time to time reasonably request provided, however, the Company shall not be required to furnish
 any documents to the Agents that are available on SEDAR+ or EDGAR.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Company Information*. The Company
 will furnish to the Agents such information in its possession as is reasonably requested
 by the Agents as necessary or appropriate to fulfil their obligations as agents pursuant
 to this Agreement, the Act and Canadian Securities Laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Compliance with Blue Sky Laws*.
 The Company shall cooperate with the Agents and their counsel therefor in connection with
 the registration or qualification (or the obtaining of exemptions therefrom) of the Shares
 for the offering and sale under the securities or Blue Sky laws of such jurisdictions as
 the Agents may reasonably request, including, without limitation, the states of the United
 States and other jurisdictions outside the United States, and to continue such registration
 or qualification in effect so long as necessary under such laws for the distribution of the
 Shares; provided, however, that in no event shall the Company be obligated to qualify to
 do business in any jurisdiction where it is not now so qualified or to take any action which
 would subject it to general service of process or ongoing reporting obligations in any jurisdiction
 where it is not now so subject (except service of process with respect to the offering and
 sale of the Shares).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) *Material Non-public Information*.
 The Company covenants that it will not issue an Agency Transaction Notice to the Agents in
 accordance with Section 1 hereof if the Company is in possession of material non-public information
 regarding the Company and its subsidiaries, taken as a whole, or the Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) *Reimbursement of Certain Expenses*. Whether or not any of the transactions contemplated by this Agreement are consummated or this Agreement is terminated,
the Company shall pay, or reimburse if paid by the Agents all costs and expenses incident to the performance of the obligations of the
Company under this Agreement, including, without limitation, costs and expenses of or relating to the preparation, printing and filing
of the Registration Statement and exhibits to it, each preliminary prospectus, each Permitted Free Writing Prospectus (as defined herein),
the Prospectuses and any amendment or supplement to the Registration Statement or the Prospectuses (including the filing fees payable
to the Commission relating to the Shares within the time required by Rule 456 of the Rules and Regulations), (ii) the preparation and
delivery of certificates, if any, representing the Shares, (iii) the printing of this Agreement, (iv) furnishing (including costs of
shipping, mailing and courier) such copies of the Registration Statement, the Prospectuses, and any Permitted Free Writing Prospectus,
and all amendments and supplements thereto, as may be requested for use in connection with the offering and sale of the Shares by the
Agents, (v) the listing of the Shares on the NYSE American and the TSX, (vi) any filings required to be made by the Agents with the Financial
Industry Regulatory Authority, Inc. ()"**FINRA** "), the Commission and the Canadian Qualifying Authorities, and the fees,
disbursements and other charges of counsel for the Agents in connection therewith, (vii) the registration or qualification of the Shares
for offer and sale under the Act and the securities or Blue Sky laws of such jurisdictions designated pursuant to subsection (f) of this
Section 3, including the fees, disbursements and other charges of U.S. counsel to the Agents in connection therewith, and, if requested
by the U.S. Agents, the preparation and printing of preliminary, supplemental and final Blue Sky or legal investment memoranda (a copy
of which shall be provided to the Company), (viii) counsel to the Company, (ix) DTC, CDS and any other depositary, transfer
agent or registrar for the Shares, (x) all reasonable out-of-pocket fees, disbursements and other charges of the Agents incurred
in connection with this Agreement, the Registration Statement, the Prospectuses and the offering of the Shares including without limitation,
the fees and disbursements of counsel to the Agents (to a maximum of US$100,000, exclusive of taxes and disbursements, for United States
and Canadian counsel plus an additional US$10,000, exclusive of taxes and disbursements, for United States and Canadian counsel per fiscal
quarter in connection with subsequent Representation Dates hereunder) and (xii) all fees, costs and expenses for consultants used by
the Company in connection with the offering of the Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) *Use of Proceeds*. The Company shall
 apply the net proceeds from the offering and sale of the Shares to be sold by the Company
 in the manner set forth in the Prospectus Supplements under "Use of Proceeds"
 and, except as disclosed in the Prospectuses, the Company does not intend to use any of the
 proceeds from the sale of the Shares to repay any outstanding debt owed to the Agents or
 any affiliate of the Agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) *Change of Circumstances*. During
 the term of this Agreement, the Company will, at any time during a fiscal quarter in which
 the Company intends to deliver an Agency Transaction Notice to the Agents to sell Shares,
 advise the Agents promptly after it has received notice or obtained knowledge thereof, of
 any information or fact that would alter or affect in any material respect any opinion, certificate,
 letter or other document provided to the Agents pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) *Due Diligence Cooperation*. The
 Company shall cooperate with any reasonable due diligence review requested by the Agents
 or their counsel from time to time in connection with the transactions contemplated hereby
 or any Agency Transaction Notice, including, without limitation, (i) prior to the open of
 trading on each intended purchase date and any Time of Sale or Settlement Date, making available
 appropriate corporate officers of the Company and, upon reasonable request, representatives
 of the accountants for the Company and an update on diligence matters with representatives
 of the Agents and their counsel and (ii) at each Representation Date (as defined herein)
 or otherwise as the Agents may reasonably request, providing information and making available
 documents and appropriate corporate officers of the Company and representatives of the accountants
 for the Company for one or more due diligence sessions with representatives of the Agents
 and their counsel.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) *Clear Market*. During a time at
 which an Agency Transaction Notice is pending or outstanding, the Company shall not offer
 to sell, sell, pledge, hypothecate, contract or agree to sell, purchase any option to sell,
 grant any option for the purchase of, lend, or otherwise dispose of, directly or indirectly,
 any Common Shares or any securities convertible into or exercisable or exchangeable for Common
 Shares or warrants or other rights to acquire Common Shares or any other securities of the
 Company that are substantially similar to the Common Shares or permit the registration under
 the Act of any Common Shares (each a "**Proposed Transaction** "), without
 giving the Agents by written notice or by draft news release sent to the Agents at least
 three business days' prior written notice to the issuance date specifying the nature
 and date of such Proposed Transaction; except that if the Company is proposing to issue securities
 under a "bought deal" or other financing transaction where the Company is not
 aware of the Proposed Transaction sufficiently in advance to allow for three business days'
 prior notice, then the Company shall notify the Agents as soon as possible upon becoming
 aware of the Proposed Transaction and in any event prior to accepting any offer or entering
 into any agreement with respect to the Proposed Transaction. Notwithstanding the foregoing,
 the Company may, without giving any such prior notice, (i) register the offering and sale
 of the Shares through the Agents pursuant to this Agreement, (ii) issue Common Shares upon
 the exercise of an option or warrant or the conversion of a convertible security outstanding
 on the date hereof and referred to in the Prospectuses, (iii) issue Common Shares, options
 or other securities convertible into or exchangeable for Common Shares pursuant to existing
 employee incentive plans of the Company or to consultants or (iv) issue Common Shares pursuant
 to any non-employee director stock plan, dividend reinvestment plan, stock purchase plan
 or other similar incentive plan of the Company or to consultants. If notice of a Proposed
 Transaction is provided by the Company pursuant to this subsection (l), the Agents may suspend
 activity of the transactions contemplated by this Agreement for such period of time as may
 be requested by the Company or as may be deemed appropriate by the Agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) *Affirmation of Representations, Warranties, Covenants and Other Agreements*. Upon commencement of the offering of the Shares under
 this Agreement (and upon the recommencement of the offering of the Shares under this Agreement
 following any suspension of sales under Section 1(a)(vi)), and at each Time of Sale, each
 Settlement Date and each Amendment Date, the Company shall be deemed to have affirmed each
 representation and warranty contained in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) *Required Filings Relating to Sale of Shares*. In each quarterly report, quarterly financial statements, quarterly and annual
 management discussion and analysis, annual information form, annual financial statements
 or annual report on Form 40-F filed by the Company in respect of any quarter or year, as
 applicable, in which sales of Shares were made by the Agents under this Agreement, the Company
 shall set forth with regard to the most recent applicable quarter or year, as applicable,
 the number of Shares and the average selling price of the Shares sold through the Agents
 under this Agreement, the gross and net proceeds received by the Company and the compensation
 paid by the Company to the Agents with respect to sales of Shares pursuant to this Agreement.
 For so long as the Shares are listed on the TSX, the Company will provide the TSX with all
 information it requires with respect to the offering of the Shares within the timelines prescribed
 by the TSX and for so long as the Shares are listed on the NYSE American, the Company will
 provide the NYSE American with all information it requires with respect to the offering of
 the Shares within the timelines prescribed by the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) *Representation Dates; Certificate*.
 During the term of this Agreement, each time the Company (i) files the Prospectuses relating
 to the Shares or amends or supplements the Registration Statement or the Prospectuses relating
 to the Shares by means of a post-effective amendment or supplement but not by means of incorporation
 of document(s) by reference to the Registration Statement or the Prospectuses relating to
 the Shares; (ii) files or amends an annual report on Form 40-F; (iii) files or amends interim
 financial statements on Form 6-K; (iv) files or amends annual financial statements pursuant
 to Canadian Securities Laws; (v) files or amends an annual information form; or (vi) at any
 other time reasonably requested by the Agents (each date of filing of one or more of the
 documents referred to in clauses (i) through (v) and any time of request pursuant to (vi)
 above shall be a "**Representation Date** "), the Company shall furnish the
 Agents with a certificate, in the form included in Section 4(d), upon execution of this Agreement
 and within three days of each Representation Date. The requirement to furnish the documents
 set out in this Section 3(o) shall be waived for any Representation Date occurring at a time
 at which no Agency Transaction Notice is pending, which waiver shall continue until the earlier
 to occur of the date the Company delivers an Agency Transaction Notice hereunder (which for
 such calendar quarter shall be considered a Representation Date), and the next occurring
 Representation Date. Notwithstanding the foregoing, if the Company subsequently decides to
 sell Shares following a Representation Date when the Company relied on such waiver, then
 before the Company delivers the Agency Transaction Notice, or the Agents sell any Shares,
 the Company shall provide the Agents with each of the documents set out in this Section 3(o).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) *Legal Opinions/Negative Assurance Letters*. On the Prospectus Supplement Filing Date and within
 three Trading Days after any Representation Date, the Company shall cause to be furnished
 to the Agents, dated the date the opinions are so furnished and addressed to the Agents,
 in form and substance satisfactory to the Agents, acting reasonably, (i) the written opinion
 of Borden Ladner Gervais LLP, Canadian counsel for the Company, as described in Section 4(e),
 and other local counsel, as required, such opinion letters to be substantially similar to
 the form attached hereto as Exhibit B but modified as necessary to relate to the Registration
 Statement and the Prospectuses as amended and supplemented to the date of such opinion, and
 (ii) the written opinion and a negative assurance letter of Troutman Pepper Locke LLP, U.S.
 counsel for the Company, as described in Section 4(e), such opinion and negative assurance
 letter, each dated the date the opinion is required to be delivered, in a form and substance
 satisfactory to the Agents and their counsel, acting reasonably, or, in lieu of such opinions,
 counsel last furnishing such opinion to the Agents may furnish the Agents with a letter to
 the effect that the Agents may rely on such last opinion to the same extent as though it
 was dated the date of such letter authorizing reliance (except that statements in such last
 opinion shall be deemed to relate to the Registration Statement and the Prospectuses as amended
 and supplemented to the time of delivery of such letter authorizing reliance). The requirement
 to furnish the documents set out in this Section 3(p) shall be waived for any Representation
 Date occurring at a time at which no Agency Transaction Notice is pending, which waiver shall
 continue until the earlier to occur of the date the Company delivers an Agency Transaction
 Notice hereunder (which for such calendar quarter shall be considered a Representation Date),
 and the next occurring Representation Date. Notwithstanding the foregoing, if the Company
 subsequently decides to sell Shares following a Representation Date when the Company relied
 on such waiver, then before the Company delivers the Agency Transaction Notice, or the Agents
 sell any Shares, the Company shall provide the Agents with each of the documents set out
 in this Section 3(p).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q) *Comfort Letters*. On the Prospectus Supplement Filing Date and within three Trading Days after
 each Representation Date, the Company shall cause its auditors to furnish the Agents a letter
 (the "**Comfort Letter**") dated the date the Comfort Letter is delivered,
 in form and substance satisfactory to the Agents, acting reasonably, addressed to the Agents,
 relating to the verification of certain of the financial information and statistical and
 accounting data relating to the Company and its Material Subsidiaries contained in the Registration
 Statement and the Prospectuses or incorporated by reference therein, which comfort letter
 shall be based on a review having a cut-off date not more than two business days prior to
 the date of such letter, (y) stating that such auditors are independent public accountants
 within the meaning of the Canadian Securities Laws, the Act and the rules and regulations
 thereunder, and that in their opinion the audited financial statements of the Company incorporated
 by reference in the Registration Statement and the Prospectuses comply as to form in all
 material respects with the published accounting requirements of the Canadian Securities Laws,
 the Act and the related regulations thereunder and with the applicable accounting requirements
 of the Canadian Securities Laws, the Act and the Exchange Act and the related published rules
 and regulations adopted by the Canadian Securities Authorities and the Commission (the first
 such letter, the "**Initial Comfort Letter**") and (z) updating the Initial
 Comfort Letter with any information which would have been included in the Initial Comfort
 Letter had it been given on such date and modified as necessary to relate to the Registration
 Statement and the Prospectuses, as amended and supplemented to the date of such letter. The
 requirement to furnish the documents set out in this Section 3(q) shall be waived for any
 Representation Date occurring at a time at which no Agency Transaction Notice is pending,
 which waiver shall continue until the earlier to occur of the date the Company delivers an
 Agency Transaction Notice hereunder (which for such calendar quarter shall be considered
 a Representation Date), and the next occurring Representation Date. Notwithstanding the foregoing,
 if the Company subsequently decides to sell Shares following a Representation Date when the
 Company relied on such waiver, then before the Company delivers the Agency Transaction Notice,
 or the Agents sell any Shares, the Company shall provide the Agents with each of the documents
 set out in this Section 3(q).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r) *Title Opinions*. On the Prospectus
 Supplement Filing Date and within five Trading Days after (i) each Amendment Date, (ii) each
 time the Company files or amends an annual information form, annual financial statements,
 or an annual report on Form 40-F, (iii) any material change to the ownership or title of
 any of the Material Property, or (iv) the determination by the Company that any property
 is material to the Company, excluding the Material Property, the Company shall cause to be
 furnished to the Agents written opinions, addressed and in form and substance satisfactory
 to the Agents and the Agents' counsel, from legal counsel to the Company located in the jurisdiction
 in which the subject Material Property (or such other material property) is situated, together
 with a certified English translation thereof for any such legal opinion not in the English
 language, with respect to the Company's (or its subsidiary's, as applicable) title and mineral
 rights comprising the Material Property (or such other material property) (the "**Title Opinions** "), provided that such Title Opinions regarding the Material Property will
 not be required in respect of Representation Dates where the Representation Date does not
 relate to a Prospectus filing and where the officer's certificate provided under Section
 4(d) has confirmed that there has been no material change to the Material Property or change
 to the ownership structure of the Material Property since the previous Representation Date
 or 3(o). In addition, the requirement to furnish the documents set out in this Section 3(r)
 shall be waived for any Representation Date occurring at a time at which no Agency Transaction
 Notice is pending, which waiver shall continue until the earlier to occur of the date the
 Company delivers an Agency Transaction Notice hereunder (which for such calendar quarter
 shall be considered a Representation Date), and the next occurring Representation Date. Notwithstanding
 the foregoing, if the Company subsequently decides to sell Shares following a Representation
 Date when the Company relied on such waiver, then before the Company delivers the Agency
 Transaction Notice, or the Agents sell any Shares, the Company shall provide the Agents with
 each of the documents set out in this Section 3(r).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s) *Corporate Opinions for Material Subsidiaries*. On the Prospectus Supplement Filing Date and within
 five Trading Days after (i) each Amendment Date and (ii) each time the Company files
 or amends an annual information form, annual financial statements, or an annual report on
 Form 40-F, the Company shall cause to be furnished to the Agents, dated the date the opinions
 are so furnished and addressed to the Agents, in form and substance satisfactory to the Agents,
 a favourable written legal opinion from legal counsel to the Company located in the jurisdictions
 in which each of the Material Subsidiaries is incorporated and conducting business as to
 the following matters: (i) each Material Subsidiary is validly existing and in good standing
 under the laws of the jurisdiction of its incorporation or formation; and (ii) each
 Material Subsidiary has all requisite corporate or limited liability power and authority,
 as applicable, and is registered or otherwise qualified to conduct the business now and as
 proposed to be conducted, and to own, lease and operate their respective properties and assets,
 including the applicable Material Property; and (iii) as to the authorized share capital
 and the issued and outstanding share capital of each Material Subsidiary (the "**Corporate Opinions** "). In addition, the requirement to furnish the documents set out in this
 Section 3(s) shall be waived for any Representation Date occurring at a time at which no
 Agency Transaction Notice is pending, which waiver shall continue until the earlier to occur
 of the date the Company delivers an Agency Transaction Notice hereunder (which for such calendar
 quarter shall be considered a Representation Date), and the next occurring Representation
 Date. Notwithstanding the foregoing, if the Company subsequently decides to sell Shares following
 a Representation Date when the Company relied on such waiver, then before the Company delivers
 the Agency Transaction Notice, or the Agents sell any Shares, the Company shall provide the
 Agents with each of the documents set out in this Section 3(s).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t) *Bring-Down Certificate*. The Company
 will on the Prospectus Supplement Filing Date, deliver a certificate to the Agents pursuant
 to section 4(d) of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u) *Market Activities*. The Company
 will not, directly or indirectly, (i) take any action designed to or that would constitute
 or that would reasonably be expected to cause or result in, under Canadian Securities Laws
 or the Exchange Act or otherwise, stabilization or manipulation of the price of any security
 of the Company to facilitate the sale or resale of the Shares or (ii) sell, bid for, or purchase
 the Shares, or pay anyone any compensation for soliciting purchases of the Shares other than
 the Agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) *Investment Company Act*. The Company
 will conduct its affairs in such a manner so as to reasonably ensure that prior to the termination
 of this Agreement, it will not be or become required to register as an "investment
 company" under the United States Investment Company Act of 1940, as amended, and the
 rules and regulations of the Commission promulgated thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(w) *Board Authorization*. Prior to delivering
 notice of the proposed terms of an Agency Transaction pursuant to Section 1 (or at such time
 as otherwise agreed between the Company and the Agents), the Company shall have obtained
 from its board of directors or a duly authorized committee thereof all necessary corporate
 authority for the sale of the Shares pursuant to the relevant Agency Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) *Offer to Refuse to Purchase*. If
 to the knowledge of the Company any condition set forth in Section 4(a) of this Agreement
 shall not have been satisfied on the applicable Settlement Date, the Company shall offer
 to any person who has agreed to purchase Shares from the Company as the result of an offer
 to purchase solicited by the Agents the right to refuse to purchase and pay for such Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(y) *Consent to the Agents' Trading*.
 The Company consents to the extent permitted under the Act, the Exchange Act, Canadian Securities
 Laws, the rules of the NYSE American or of the TSX, and under this Agreement, to the Agents
 trading in the Common Shares: (i) for the account of their clients at the same time as sales
 of Shares occur pursuant to this Agreement; and (ii) for the Agents' own accounts,
 provided that in the case of the clause (ii), no such purchase or sale shall take place by
 an Agent while such Agent has received an Agency Transaction Notice that remains in effect,
 unless the Company has expressly authorized or consented in writing to any such trades by
 such Agent, and provided further that in the case of clauses (i) and (ii), by providing such
 consent, the Company will incur no liability on behalf of the Agents or their clients resulting
 from such trading activity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(z) *Permitted Free Writing Prospectuses*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The Company represents and agrees that it
 has not made and, unless it obtains the prior written consents of the Agents, shall not make,
 any offer relating to the Shares that would constitute a "free writing prospectus"
 as defined in Rule 405 of the Rules and Regulations, which is required to be retained by
 the Company under Rule 433 of the Rules and Regulations; provided that the prior written
 consents of the Agents hereto shall be deemed to have been given in respect of each of the
 free writing prospectuses set forth in Schedule 3 hereto. Any such free writing prospectus
 consented to by the Agents is herein referred to as a "Permitted Free Writing Prospectus."
 The Company represents and agrees that (i) it has treated and shall treat, as the case may
 be, each Permitted Free Writing Prospectus as a "free writing prospectus" as
 defined in Rule 405 of the Rules and Regulations and (ii) it has complied and shall comply,
 as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any
 Permitted Free Writing Prospectus, including, without limitation, in respect of timely filing
 with the Commission, legending and record keeping. The Company agrees not to take any action
 that would result in the Agents or the Company being required to file pursuant to Rule 433(d)
 under the Act a free writing prospectus prepared by or on behalf of the Agents that the Agents
 otherwise would not have been required to file thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The Company agrees that no Permitted Free
 Writing Prospectus, if any, will include any information that conflicts with the information
 contained in the Registration Statement or the Prospectuses, including any document incorporated
 by reference therein that has not been superseded or modified. In addition, no Permitted
 Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement
 of a material fact or omit to state a material fact necessary to make the statements therein,
 in light of the circumstances under which they were made, not misleading; provided, however,
 the foregoing shall not apply to any statements in or omissions from any Permitted Free Writing
 Prospectus made in reliance on and in conformity with information relating to the Agents
 furnished in writing to the Company by or on behalf of the Agents expressly for inclusion
 therein, it being understood and agreed that the only such information is as described in
 Section 5(b) hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The Company agrees that if at any time
 following issuance of a Permitted Free Writing Prospectus any event occurred or occurs as
 a result of which such Permitted Free Writing Prospectus would conflict with the information
 in the Registration Statement or in the Prospectuses, including any document incorporated
 by reference therein that has not been superseded or modified, or would include an untrue
 statement of a material fact or omit to state a material fact necessary to make the statements
 therein, in light of the circumstances under which they were made, not misleading, the Company
 will give prompt notice thereof to the Agents and, if requested by the Agents, will prepare
 and furnish without charge to the Agents a Permitted Free Writing Prospectus or other document
 which will correct such conflict, statement or omission; provided, however, the foregoing
 shall not apply to any statements in or omissions from any Permitted Free Writing Prospectus
 made in reliance on and in conformity with information relating to the Agents furnished in
 writing to the Company by or on behalf of the Agents expressly for inclusion therein, it
 being understood and agreed that the only such information is as described in Section 5(b)
 hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(aa) *Distribution of Offering Materials*.
 The Company has not distributed and will not distribute, during the term of this Agreement,
 any "marketing materials" (as defined in National Instrument 41-101 — *General Prospectus Requirements*) solely connected to the offering and sale of the Shares other
 than the Registration Statement, the Prospectuses or any Permitted Free Writing Prospectus
 reviewed and consented to by the Agents and included in an Agency Transaction Notice, provided
 that the Agents, severally and not jointly, covenant with the Company not to take any action
 that would result in the Company being required to file with the Canadian Qualifying Authorities
 any "marketing materials" that otherwise would not be required to be filed by
 the Company, but for the action of the Agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(bb) *Purchases under Normal Course Issuer Bid*. Without having first agreed with the applicable Agent, acting reasonably, as to
 the appropriate adjustments, if any, to be made to the parameters set forth in such Agency
 Transaction Notice, the Company will not purchase Common Shares, and not permit any of its
 affiliates or any person acting on its behalf to purchase Common Shares, under a normal course
 issuer bid throughout (i) any period during which an Agency Transaction Notice is pending
 or effective, and (ii) the period beginning on the second business day immediately prior
 to the date on which any Agency Transaction Notice is delivered to the Agents hereunder and
 ending on the second business day immediately following the final Settlement Date with respect
 to the Shares sold pursuant to such Agency Transaction Notice.

4. <u>Conditions to the Agents' Obligations</u>.
 The obligations of the Agents hereunder are subject to (i) the accuracy of the representations
 and warranties of the Company on the date hereof, on each Representation Date and as of each
 Time of Sale and each Settlement Date, (ii) the performance of the Company of its obligations
 hereunder and (iii) the following additional conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Canadian Prospectus Supplement*.
 The Canadian Prospectus Supplement shall have been filed with the Canadian Qualifying Authorities
 on the Prospectus Supplement Filing Date under the Canadian Shelf Procedures and in accordance
 with this Agreement and all requests for additional information on the part of the Canadian
 Qualifying Authorities shall have been complied with to the reasonable satisfaction of the
 Agents and Agents' counsel and the Translation Decision shall remain in full force
 and effect without amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *No Material Adverse Changes*. Since
 the date of the most recent financial statements of the Company included or incorporated
 by reference in the Registration Statement and the Prospectuses, except as described in the
 Registration Statement and the Prospectuses, there shall not have been a Material Adverse
 Change.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *No Material Notices*. None of the
 following events shall have occurred and be continuing: (i) receipt by the Company of any
 request for additional information from the Commission, the Canadian Qualifying Authorities
 or any other federal, provincial, territorial or state or foreign or other governmental,
 administrative or self-regulatory authority during the period of effectiveness of the Registration
 Statement and the Prospectuses, the response to which would require any amendments or supplements
 to the Registration Statement or the Prospectuses; (ii) the issuance by the Commission, the
 Canadian Qualifying Authorities or any other federal, provincial, territorial or state or
 foreign or other governmental authority of any stop order suspending the effectiveness of
 the Registration Statement or the Prospectuses or the initiation of any proceedings for that
 purpose; (iii) receipt by the Company of any notification with respect to the suspension
 of the qualification or exemption from qualification of any of the Shares for sale in any
 jurisdiction or the initiation or threatening of any proceeding for such purpose; (iv) the
 occurrence of any event that makes any statement made in the Registration Statement or the
 Prospectuses or any document incorporated or deemed to be incorporated therein by reference
 untrue in any material respect or that requires the making of any changes in the Registration
 Statement, the Prospectuses or any document incorporated or deemed to be incorporated therein
 by reference so that, in the case of the Registration Statement, it will not contain any
 untrue statement of a material fact or omit to state any material fact required to be stated
 therein or necessary to make the statements therein not misleading, and in the case of each
 of the Prospectuses, it will not contain any untrue statement of a material fact or omit
 to state any material fact required to be stated therein or necessary to make the statements
 therein, in the light of the circumstances under which they were made, not misleading; and
 (v) the Company having reasonably determined that a post-effective amendment to the Registration
 Statement or the Prospectuses would be appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Officers' Certificates*. The
 Agents shall have received, on the Prospectus Supplement Filing Date and on each Representation
 Date, one or more certificates, dated such date and signed by at least two executive officers
 of the Company, in form and substance satisfactory to the Agents, to the effect set forth
 in clauses (b) and (c) above and to the effect that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) each signatory of such certificate has carefully
 examined the Registration Statement, the Prospectuses (including any documents filed under
 the Exchange Act and Canadian Securities Laws and deemed to be incorporated by reference
 into the Prospectuses) and each Permitted Free Writing Prospectus, if any;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) as of such date and as of each Time of Sale subsequent to the immediately
preceding Representation Date, neither the Registration Statement, the Prospectuses nor any Permitted Free Writing Prospectus contained
any untrue statement of a material fact or omitted to state any material fact necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) each of the representations and warranties of the Company contained
in this Agreement are, as of such date and as of each Time of Sale subsequent to the immediately preceding Representation Date, true and
correct in all material respects, other than those that are qualified by materiality, which shall be true and correct in all respects;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) each of the covenants and agreements required
 herein to be performed by the Company on or prior to such date has been duly, timely and
 fully performed and each condition herein required to be complied with by the Company on
 or prior to such date has been duly, timely and fully complied with.

Notwithstanding the above, the requirement to furnish the documents set out in this Section 4(d) shall be waived for any Representation Date occurring at a time at which no Agency Transaction Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers an Agency Transaction Notice hereunder (which for such calendar quarter shall be considered a Representation Date), and the next occurring Representation Date. Notwithstanding the foregoing, if the Company subsequently decides to sell Shares following a Representation Date when the Company relied on such waiver, then before the Company delivers the Agency Transaction Notice, or the Agents sell any Shares, the Company shall provide the Agents with each of the documents set out in this Section 4(d).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Legal Opinions/Negative Assurance Letters*.
 The Agents shall have received the opinions of counsel and negative assurance letter to be
 delivered pursuant to Section 3(p) on or before the date on which such delivery of such opinions
 or negative assurance letter are required pursuant to Section 3(p). In addition, on such
 dates that the opinions required by Section 3(p) are delivered, the Agents shall have also
 received the opinion and negative assurance letter of DLA Piper LLP (US), U.S. counsel to
 the Agents, with respect to such matters as the Agents may reasonably require, it being understood
 that counsel for the Agents and counsel for the Company may rely upon the opinions of local
 counsel as to all matters not governed by the laws of the respective jurisdictions in which
 they are qualified to practice, and may rely, to the extent appropriate in the circumstances,
 as to matters of fact on certificates of the Company, auditors and public officials, and
 that the opinions of counsel may be subject to usual qualifications as to equitable remedies,
 creditors' rights laws and public policy considerations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Comfort Letter*. The Agents shall
 have received the Comfort Letter required to be delivered pursuant to Section 3(q) on or
 before the date on which such delivery of such letter is required pursuant to Section 3(q).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) *Title Opinions.* The Agents shall have received the Title Opinions to
be delivered pursuant to Section 3(r) on or before the date on which such delivery of such Title Opinions is required pursuant to Section
3(r).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) *Corporate Opinions of Material Subsidiaries*.
 The Agents shall have received the opinions to be delivered pursuant to Section 3(s) on or
 before the date on which such delivery of such opinions is required pursuant to Section 3(s).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) *Due Diligence*. The Company shall
 have complied with all of its due diligence obligations required pursuant to Section 3(k).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) *Compliance with Blue Sky Laws*.
 The Shares shall be qualified for sale in such states and jurisdictions in the United States
 as the Agents may reasonably request, as well as such jurisdictions outside the United States
 as the Agents may reasonably request, in compliance with Section 3(f) and each such qualification
 shall be in effect and not subject to any stop order or other proceeding on the relevant
 Representation Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) *Stock Exchange Listing*. The Shares
 shall have been conditionally approved for listing on the TSX, subject only to subject only
 to fulfilling customary conditions with the TSX, at or prior to the delivery by the Company
 of the first Agency Transaction Notice, and the NYSE American shall have authorized the listing
 of Shares distributed under the offering of Shares at or prior to the delivery by the Company
 of the first Agency Transaction Notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) *Securities Act Filings Made*. All
 filings with the Commission required by General Instruction II.L of Form F-10 and the Act,
 and all filings required by the Canadian Qualifying Authorities, to have been filed prior
 to the issuance of any Agency Transaction Notice hereunder shall have been made within the
 applicable time period prescribed for such filing by General Instruction II.L of Form F-10,
 the Act and Canadian Securities Laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) *FINRA*. If a filing with FINRA is
 required, FINRA shall not have objected to the fairness or reasonableness of the terms or
 arrangements under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) *Additional Certificates.* The Company
 shall have furnished to the Agents such certificate or certificates, in addition to those
 specifically mentioned herein, as the Agents may have reasonably requested as to the accuracy
 and completeness at each Representation Date of any statement in the Registration Statement
 or the Prospectuses or any documents filed under the Exchange Act and Canadian Securities
 Laws and deemed to be incorporated by reference into the Prospectuses, as to the accuracy
 at such Representation Date of the representations and warranties of the Company herein,
 as to the performance by the Company of its obligations hereunder, or as to the fulfillment
 of the conditions concurrent and precedent to the obligations hereunder of the Agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) *Press Release*. Concurrently with
 the execution of this Agreement, the Company shall have issued and disseminated, and filed
 with the Canadian Qualifying Authorities, a news release (i) announcing that the Company
 has entered into this Agreement, (ii) indicating that the Prospectus Supplements have been
 or will be filed, (iii) specifying where and how a purchaser of Shares may obtain a copy
 of this Agreement and the Prospectuses and (iv) if applicable, that the completion of the
 distribution of Shares would constitute a material fact or material change. Promptly after
 the execution of this Agreement, and in any event before any sales of Shares are made hereunder,
 the Company shall file this Agreement with the Canadian Qualifying Authorities in accordance
 with applicable Canadian Securities Laws.

5. <u>Indemnification</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Indemnification of the Agents*.
 The Company shall indemnify and hold harmless each of the Agents, the directors, officers,
 employees, counsel and agents of each of the Agents and each person, if any, who controls
 any Agent within the meaning of Section 15 of the Act or Section 20 of the Exchange Act from
 and against any and all losses, claims, liabilities, expenses and damages (including, without
 limitation, any and all investigative, legal and other expenses reasonably incurred in connection
 with, and any amount paid in settlement of, any action, suit or proceeding between any of
 the indemnified parties and any indemnifying parties or between any indemnified party and
 any third party, or otherwise, or any claim asserted), to which they, or any of them, may
 become subject under the Act, the Exchange Act, Canadian Securities Laws or other federal,
 provincial, territorial or state statutory law or regulation, at common law or otherwise,
 insofar as such losses, claims, liabilities, expenses or damages arise out of or are based
 on (i) any untrue statement or alleged untrue statement of a material fact contained in the
 Registration Statement (or any amendment thereto), including all documents incorporated therein
 by reference, or the omission or alleged omission therefrom of a material fact required to
 be stated therein or necessary to make the statements therein not misleading or (ii) any
 untrue statement or alleged untrue statement of a material fact contained in any Permitted
 Free Writing Prospectus or the Prospectuses (or any amendment or supplement thereto) or the
 omission or alleged omission therefrom of a material fact necessary in order to make the
 statements therein, in the light of the circumstances under which they were made, not misleading
 or (iii) any untrue statement or alleged untrue statement of a material fact contained in
 any materials or information provided to investors by, or with the approval of, the Company
 in connection with the marketing of the offering of the Shares, including any roadshow or
 investor presentations made to investors by the Company (whether in person or electronically)
 or the omission or alleged omission therefrom of a material fact necessary in order to make
 the statements therein, in the light of the circumstances under which they were made, not
 misleading; provided, however, that the Company shall not be liable to the extent that such
 loss, claim, liability, expense or damage arises from the sale of the Shares in the public
 offering to any person by the Agents and is based on an untrue statement or omission or alleged
 untrue statement or omission made in reliance on and in conformity with information relating
 to the Agents furnished in writing to the Company by the Agents expressly for inclusion in
 the Registration Statement, the Prospectuses or any Permitted Free Writing Prospectus, it
 being understood and agreed that the only such information is as described in Section 5(b)
 hereof. This indemnity will be in addition to any liability that the Company might otherwise
 have.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Indemnification of the Company*.
 Each Agent shall, severally and not jointly, indemnify and hold harmless the Company, its
 agents, each person, if any, who controls the Company within the meaning of Section 15 of
 the Act or Section 20 of the Exchange Act, each director of the Company and each officer
 of the Company who signs the Registration Statement to the same extent as the foregoing indemnity
 from the Company to the Agents, but only insofar as losses, claims, liabilities, expenses
 or damages arise out of or are based on any untrue statement or omission or alleged untrue
 statement or omission made in reliance on and in conformity with information relating to
 an Agent furnished in writing to the Company by or on behalf of an Agent expressly for inclusion
 in the Registration Statement, any Permitted Free Writing Prospectus or the Prospectuses.
 This indemnity will be in addition to any liability that the Agents might otherwise have. The
 Company acknowledges and agrees that the names of the Agents set forth on the front and back
 covers and on the certificate of the Agents in the Prospectus Supplements, and the eight,
 tenth and thirteenth paragraphs under the heading "Plan of Distribution" in the
 Prospectus Supplements, constitute the only information furnished in writing by or on behalf
 of the Agents for inclusion in the Registration Statement, any Permitted Free Writing Prospectus
 or the Prospectuses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Indemnification Procedures*. Any
 party that proposes to assert the right to be indemnified under this Section 5 shall, promptly
 after receipt of notice of commencement of any action against such party in respect of which
 a claim is to be made against an indemnifying party or parties under this Section 5, notify
 each such indemnifying party of the commencement of such action, enclosing a copy of all
 papers served, but the omission so to notify such indemnifying party shall not relieve the
 indemnifying party from any liability that it may have to any indemnified party under the
 foregoing provisions of this Section 5 unless, and only to the extent that, such omission
 results in the forfeiture of substantive rights or defenses by the indemnifying party or
 results in any increase in the liability under this indemnity that the indemnifying party
 would not otherwise have incurred had the indemnified party given the required notice. If
 any such action is brought against any indemnified party and it notifies the indemnifying
 party of its commencement, the indemnifying party will be entitled to participate in and,
 to the extent that it elects by delivering written notice to the indemnified party promptly
 after receiving notice of the commencement of the action from the indemnified party, jointly
 with any other indemnifying party similarly notified, to assume the defense of the action,
 with counsel satisfactory to the indemnified party, and after notice from the indemnifying
 party to the indemnified party of its election to assume the defense, the indemnifying party
 will not be liable to the indemnified party for any legal or other expenses except as provided
 below and except for the reasonable costs of investigation subsequently incurred by the indemnified
 party in connection with the defense. The indemnified party will have the right to employ
 its own counsel in any such action, but the fees, expenses and other charges of such counsel
 will be at the expense of such indemnified party unless (i) the employment of counsel by
 the indemnified party has been authorized in writing by the indemnifying party, (ii) the
 indemnified party has reasonably concluded (based on advice of counsel) that there may be
 legal defenses available to it or other indemnified parties that are different from or in
 addition to those available to the indemnifying party, (iii) a conflict or potential conflict
 exists (based on advice of counsel to the indemnified party) between the indemnified party
 and the indemnifying party (in which case the indemnifying party shall not have the right
 to direct the defense of such action on behalf of the indemnified party) or (iv) the indemnifying
 party has not in fact employed counsel to assume the defense of such action within a reasonable
 time after receiving notice of the commencement of the action, in each of which cases the
 reasonable and documented fees, disbursements and other charges of counsel shall be at the
 expense of the indemnifying party or parties. Notwithstanding the foregoing sentence, it
 is understood that the indemnifying party or parties shall not, in connection with any proceeding
 or related proceedings in the same jurisdiction, be liable for the reasonable and documented
 fees, disbursements and other charges of more than one separate firm admitted to practice
 in such jurisdiction at any one time for all such indemnified parties in the event that the
 indemnifying party is responsible for such firm's fees, disbursements and other charges
 pursuant to the foregoing sentence. All such fees, disbursements and other charges shall
 be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party
 shall not be liable for any settlement of any action or claim effected without its written
 consent (which consent will not be unreasonably withheld or delayed). No indemnifying party
 shall, without the prior written consent of each indemnified party, settle or compromise
 or consent to the entry of any judgment in any pending or threatened claim, action or proceeding
 relating to the matters contemplated by this Section 5 (whether or not any indemnified party
 is a party thereto), unless such settlement, compromise or consent (i) includes an unconditional
 release of each indemnified party from all liability arising or that may arise out of such
 claim, action or proceeding and (ii) does not include a statement as to or an admission of
 fault, culpability or a failure to act by or on behalf of any indemnified party. Notwithstanding
 the foregoing, if at any time an indemnified party shall have requested an indemnifying party
 to reimburse the indemnified party for fees and expenses of counsel as contemplated by this
 Section 5(c), the indemnifying party agrees that it shall be liable for any settlement of
 any proceeding effected without its written consent if (i) such settlement is entered into
 more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii)
 such indemnifying party shall have received notice of the terms of such settlement at least
 30 days prior to such settlement being entered into and (iii) such indemnifying party shall
 not have reimbursed such indemnified party in accordance with such request prior to the date
 of such settlement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Contribution*. In order to provide
 for just and equitable contribution in circumstances in which the indemnification provided
 for in the foregoing paragraphs of this Section 5 is applicable in accordance with its terms
 but for any reason is held to be unavailable from the Company or the Agents, the Company
 and the Agents shall contribute to the total losses, claims, liabilities, expenses and damages
 (including, without limitation, any investigative, legal and other expenses reasonably incurred
 in connection with, and any amount paid in settlement of, any action, suit or proceeding
 or any claim asserted) to which the Company and the Agents may be subject in such proportion
 as shall be appropriate to reflect the relative benefits received by the Company on the one
 hand and the Agents on the other hand. The relative benefits received by the Company on the
 one hand and the Agents on the other hand shall be deemed to be in the same proportion as
 the total net proceeds from the offering of the Shares (before deducting expenses) received
 by the Company to the sum of (i) the total compensation actually received by the Agents pursuant
 to Section 1(a)(ix) (in the case of one or more Agency Transactions hereunder) and (ii) the
 underwriting discounts and commissions actually received by the Agents as set forth in the
 table on the cover page of the Prospectuses. If, but only if, the allocation provided by
 the foregoing sentence is not permitted by applicable law, the allocation of contribution
 shall be made in such proportion as is appropriate to reflect not only the relative benefits
 referred to in the foregoing sentence but also the relative fault of the Company, on the
 one hand, and the Agents, on the other hand, with respect to the statements or omissions
 which resulted in such loss, claim, liability, expense or damage or action in respect thereof,
 as well as any other relevant equitable considerations with respect to such offering. Such
 relative fault shall be determined by reference to whether the untrue or alleged untrue statement
 of a material fact or omission or alleged omission to state a material fact relates to information
 supplied by the Company or the Agents, the intent of the parties and their relative knowledge,
 access to information and opportunity to correct or prevent such statement or omission. The
 amount paid or payable by an indemnified party as a result of the loss, claim, liability,
 expense or damage, or action in respect thereof, referred to above in this subsection (d)
 shall be deemed to include, for purpose of this subsection (d), any legal or other expenses
 reasonably incurred by such indemnified party in connection with investigating or defending
 any such action or claim. Notwithstanding the provisions of this subsection (d), the Agents
 shall not be required to contribute any amount in excess of the sum of (i) the total compensation
 actually received by the Agents pursuant to Section 1(a)(ix) (in the case of one or more
 Agency Transactions hereunder) and (ii) the underwriting discounts and commissions actually
 received by the Agents as set forth in the table on the cover page of the Prospectuses, and
 no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
 of the Act) shall be entitled to contribution from any person who was not guilty of such
 fraudulent misrepresentation. For purposes of this subsection (d), any person who controls
 a party to this Agreement within the meaning of the Act will have the same rights to contribution
 as that party, and each officer of the Company who signed the Registration Statement will
 have the same rights to contribution as the Company, subject in each case to the provisions
 hereof. Any party entitled to contribution, promptly after receipt of notice of commencement
 of any action against such party in respect of which a claim for contribution may be made
 under this subsection (d), will notify any such party from whom contribution may be sought,
 but the omission so to notify will not relieve the party from whom contribution may be sought
 from any other obligation it may have under this subsection (d) unless, and only to the extent
 that, such omission results in any increase in the liability to contribute pursuant to this
 subsection (d) that the party would not otherwise have had the other contributing party given
 notice. No party will be liable for contribution with respect to any action or claim settled
 without its written consent (which consent will not be unreasonably withheld).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Beneficiaries*. The obligations
 of the Company under this Section 5 shall be in addition to any liability which the Company
 may otherwise have and shall extend, upon the same terms and conditions, to any affiliate
 of an Agent and each person, if any, who controls an Agent or any such affiliate within the
 meaning of the Act; and the obligations of the Agents under this Section 5 shall be in addition
 to any liability which it may otherwise have and shall extend, upon the same terms and conditions,
 to each officer and director of the Company and to each person, if any, who controls the
 Company within the meaning of the Act.

6. <u>Termination</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company may terminate this Agreement
 in its sole discretion at any time upon giving prior written notice to the Agents. Any such
 termination shall be without liability of any party to the other party, except that (i) with
 respect to any pending sale, the obligations of the Company, including, without limitation,
 in respect of compensation of the Agents, shall remain in full force and effect notwithstanding
 such termination; and (ii) the provisions of Sections 2 (*Representations and Warranties of the Company*), 3 (*Agreements of the Company*) (except that if no Shares have
 been previously sold hereunder, only Section 3(h) (*Reimbursement of Certain Expenses*),
 5 (*Indemnification*), 8(d) (*Survival of Representations and Warranties*), 8(f)
 (*Governing Law*) and 8(l) (*Waiver of Jury Trial*) of this Agreement shall remain
 in full force and effect notwithstanding such termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any Agent may terminate its obligations
 under this Agreement solely with respect to such Agent in its sole discretion at any time
 upon giving prior written notice to the Company. Any such termination shall be without liability
 of any party to another party, except that (i) with respect to any pending sale, the obligations
 of the Company, including, without limitation, in respect of compensation of the Agents,
 shall remain in full force and effect notwithstanding such termination; and (ii) the provisions
 of Sections 2 (*Representations and Warranties of the Company*), 3 (*Agreements of the Company*) (except that if no Shares have been previously sold hereunder, only Section
 3(h) (*Reimbursement of Certain Expenses*), 5 (*Indemnification*), 8(d) (*Survival of Representations and Warranties*), 8(f) (*Governing Law*) and 8(l) (*Waiver of Jury Trial*) of this Agreement shall remain in full force and effect notwithstanding such
 termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) This Agreement shall remain in full force
 and effect until the earliest to occur of (A) termination of this Agreement pursuant to subsection
 (a) or (b) above or otherwise by mutual written agreement of the parties, (B) such date that
 the aggregate gross sales proceeds of the Shares sold pursuant to this Agreement equals the
 Maximum Amount and (C) February 27, 2028, in each case except that (i) with respect to any
 pending sale, the obligations of the Company, including, without limitation, in respect of
 compensation of the Agents, shall remain in full force and effect notwithstanding such termination;
 and (ii) the provisions of Sections 2 (*Representations and Warranties of the Company*),
 3 (*Agreements of the Company*) (except that if no Shares have been previously sold
 hereunder, only Section 3(h) (*Reimbursement of Certain Expenses*), 5 (*Indemnification*),
 8(d) (*Survival of Representations and Warranties*), 8(f) (*Governing Law*) and
 8(l) (*Waiver of Jury Trial*) of this Agreement shall remain in full force and effect
 notwithstanding such termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Any termination of this Agreement shall
 be effective on the date specified in the notice of termination; provided that such termination
 shall not be effective until the close of business on the date of receipt of such notice
 by the Agents or the Company, as the case may be. If such termination shall occur prior to
 the Settlement Date for any sale of Shares, such sale shall settle in accordance with the
 provisions of Section 1.

7. <u>Recognition of the U.S. Special Resolution Regimes</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In the event that any Agent that is a
 Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the
 transfer from such Agent of this Agreement, and any interest and obligation in or under this
 Agreement, will be effective to the same extent as the transfer would be effective under
 the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation,
 were governed by the laws of the United States or a state of the United States.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) In the event that any Agent that is a
 Covered Entity or a BHC Act Affiliate of such Agent becomes subject to a proceeding under
 a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised
 against such Agent are permitted to be exercised to no greater extent than such Default Rights
 could be exercised under the U.S. Special Resolution Regime if this Agreement were governed
 by the laws of the United States or a state of the United States.

For purposes of this Section 7:

"**BHC Act Affiliate**" has the meaning assigned to the term "affiliate" in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).

"**Covered Entity**" means any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) "**covered entity**" as that
 term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) "**covered bank**" as that
 term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) "**covered FSI**" as that
 term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).

"**Default Right**" has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.

"**U.S. Special Resolution Regime**" means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.

8. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Notices*. Notice given pursuant
 to any of the provisions of this Agreement shall be in writing and, unless otherwise specified,
 shall be mailed, hand delivered or emailed: (i) if to the Agents, at the offices of:

BMO Nesbitt Burns Inc.

885 West Georgia Street, Suite 1700

Vancouver, British Columbia V6C 3E8

Attention: Carter Hohmann

Email: [REDACTED - PERSONAL INFORMATION]

- and -

BMO Capital Markets Corp.,

151 W 42nd Street,

New York, New York 10036,

Attention: Brad Pavelka

Email: [REDACTED - PERSONAL INFORMATION]

- and -

Cantor Fitzgerald Canada Corporation

181 University Avenue, Suite 1500

Toronto, Ontario

M5H 3M7

Attention: Elan Shevel

Email: [REDACTED - PERSONAL INFORMATION]

- and –

Cantor Fitzgerald & Co

110 East 59<sup>th</sup> Street

New York, New York 10022

Attention: Global Head of Investment Banking/General Counsel

Email: [REDACTED - PERSONAL INFORMATION]

- and -

H.C. Wainwright & Co., LLC

430 Park Avenue

New York, New York 10022

Attention: Chief Executive Officer

Email: [REDACTED - PERSONAL INFORMATION]

- and -

Maxim Group LLC

300 Park Avenue, 16<sup>th</sup> Floor

New York, NY 10022

Attention: James Siegel, General Counsel

Email: [REDACTED - PERSONAL INFORMATION]

- and -

DLA Piper (Canada) LLP

Suite 2700, The Stack

1133 Melville Street

Vancouver, British Columbia V6E 4E5

Attention: Nafeesa Valli-Hasham

Email: [REDACTED - PERSONAL INFORMATION]

- and -

DLA Piper LLP (US)

1251 Ave. of the Americas

New York, New York 10020

Attention: Joshua A. Kaufman. Esq. and Andrew Ledbetter

Email: [REDACTED - PERSONAL INFORMATION]

or if sent to the Company, at the office of the Company:

Titan Mining Corporation

Suite 555, 999 Canada Place

Vancouver, BC V6C 3E1

Attention: Rita Adiani, President and Chief Executive Officer

Email: [REDACTED - PERSONAL INFORMATION]

With a copy to:

Borden Ladner Gervais LLP

Waterfront Centre

200 Burrard Street

Vancouver, British Columbia V7X 1T2

Attention: Graeme Martindale

Email: [REDACTED - PERSONAL INFORMATION]

- and -

Troutman Pepper Locke LLP

401 9<sup>th</sup> Street NW #1000<br> Washington, D.C. 20004<br> United States

Attention: Thomas M. Rose

Email: [REDACTED - PERSONAL INFORMATION]

Any such notice shall be effective (ii) when sent, if emailed, (iii) upon receipt, if hand delivered, or (iv) five business days after being deposited in the U.S. mail or Canada post, postage prepaid, if sent by mail. Any notice under Section 8(a) may be made by telecopy or telephone, but if so made shall be subsequently confirmed in writing (which may include, in the case of the Agents, electronic mail to any two Authorized Company Representatives). Any party to this Agreement may change its address for notice by notice to the other parties to this Agreement given in the manner provided for by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Consent to Jurisdiction*. The Company
 irrevocably (i) agrees that any legal suit, action or proceeding against the Company brought
 by an Agent or by any person who controls an Agent arising out of or based upon this Agreement
 or the transactions contemplated thereby may be instituted in the courts of the province
 of British Columbia, (ii) waives, to the fullest extent it may effectively do so, any objection
 which it may now or hereafter have to the laying of venue of any such proceeding and (iii)
 submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding.
 To the extent that the Company has or hereafter may acquire any immunity from jurisdiction
 of any court or from any legal process (whether through service of notice, attachment prior
 to judgment, attachment in aid of execution, execution or otherwise) with respect to itself
 or its property, it hereby irrevocably waives such immunity in respect of its obligations
 under the above-referenced documents, to the extent permitted by law. The provisions of this
 Section 8(b) shall survive any termination of this Agreement, in whole or in part.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *No Third Party Beneficiaries*. The
 Company acknowledges and agrees that the Agents are acting solely in the capacity of arm's
 length contractual counterparties to the Company with respect to the offering of Shares contemplated
 hereby (including in connection with determining the terms of the offering) and not as financial
 advisors or fiduciaries to, or agents of, the Company or any other person. Additionally,
 the Agents are not advising the Company or any other person as to any legal, tax, investment,
 accounting or regulatory matters in any jurisdiction. The Company shall consult with its
 own advisors concerning such matters and shall be responsible for making its own independent
 investigation and appraisal of the transactions contemplated hereby, and the Agents shall
 have no responsibility or liability to the Company with respect thereto. Any review by the
 Agents of the Company, the transactions contemplated hereby or other matters relating to
 such transactions will be performed solely for the benefit of the Agents and shall not be
 on behalf of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Survival of Representations and Warranties*.
 All representations, warranties and agreements of the Company contained herein or in certificates
 or other instruments delivered pursuant hereto shall remain operative and in full force and
 effect regardless of any investigation made by or on behalf of the Agents or any of their
 controlling persons and shall survive delivery of and payment for the Shares hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Disclaimer of Fiduciary Relationship*.
 The Company acknowledges and agrees that (i) the purchase and sale of the Shares pursuant
 to this Agreement, including the determination of the terms of the offering and any related
 discounts and commissions, is an arm's-length commercial transaction between the Company,
 on the one hand, and the Agents, on the other hand, (ii) in connection with the offering
 contemplated by this Agreement and the process leading to such transaction, the Agents owe
 no fiduciary duties to the Company or its securityholders, creditors, employees or any other
 party, (iii) the Agents have not assumed nor will they assume any advisory or fiduciary responsibility
 in favor of the Company with respect to the offering of the Shares contemplated by this Agreement
 or the process leading thereto (irrespective of whether the Agents or their affiliates have
 advised or are currently advising the Company on other matters) and the Agents have no obligation
 to the Company with respect to the offering of the Shares contemplated by this Agreement
 except the obligations expressly set forth in this Agreement, (iv) the Agents and their affiliates
 may be engaged in a broad range of transactions that involve interests that differ from those
 of the Company and (v) the Agents have not provided any legal, accounting, regulatory or
 tax advice with respect to the offering contemplated by this Agreement and the Company has
 consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed
 appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) *Governing Law.* THIS AGREEMENT,
 AND ANY DISPUTE, CLAIM OR CONTROVERSY ARISING UNDER OR RELATED TO THIS AGREEMENT, SHALL BE
 GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE
 TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE. EACH PARTY HERETO HEREBY
 IRREVOCABLY SUBMITS FOR PURPOSES OF ANY ACTION ARISING FROM THIS AGREEMENT BROUGHT BY THE
 OTHER PARTY HERETO TO THE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK LOCATED IN
 THE BOROUGH OF MANHATTAN AND THE U.S. DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) *Judgment Currency*. The Company
 agrees to indemnify each Agent, their directors, officers, affiliates and each person, if
 any, who controls an Agent within the meaning of Section 15 of the Act or Section 20 of the
 Exchange Act, against any loss incurred by the Agents as a result of any judgment or order
 being given or made for any amount due hereunder and such judgment or order being expressed
 and paid in a currency (the "**judgment currency**") other than U.S.
 dollars and as a result of any variation as between (i) the rate of exchange at which the
 U.S. dollar amount is converted into the judgment currency for the purpose of such judgment
 or order, and (ii) the rate of exchange at which such indemnified person is able to purchase
 U.S. dollars with the amount of the judgment currency actually received by the indemnified
 person. The foregoing indemnity shall constitute a separate and independent obligation of
 the Company and shall continue in full force and effect notwithstanding any such judgment
 or order as aforesaid. The term "rate of exchange" shall include any premiums
 and costs of exchange payable in connection with the purchase of, or conversion into, the
 relevant currency.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) *Compliance with USA Patriot Act*.
 In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed
 into law October 26, 2001)), the Agents are required to obtain, verify and record information
 that identifies their respective clients, including the Company, which information may include
 the name and address of their respective clients, as well as other information that will
 allow the Agents to properly identify their respective clients.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) *TMX Group*. The Company hereby acknowledges
 that certain of the Agents, or affiliates thereof, own or control an equity interest in TMX
 Group Limited ()"**TMX Group**") and may have a nominee director serving on
 the TMX Group's board of directors. As such, such investment dealers may be considered
 to have an economic interest in the listing of securities on any exchange owned or operated
 by TMX Group, including the TSX, the TSX Venture Exchange and the Alpha Exchange. No person
 or company is required to obtain products or services from TMX Group or its affiliates as
 a condition of any such dealer supplying or continuing to supply a product or service.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) *Counterparts*. This Agreement may
 be signed in two or more counterparts with the same effect as if the signatures thereto and
 hereto were upon the same instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) *Survival of Provisions*. In case
 any provision in this Agreement shall be invalid, illegal or unenforceable, the validity,
 legality and enforceability of the remaining provisions shall not in any way be affected
 or impaired thereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) *Waiver of Jury Trial*. Each of the
 Company and each of the Agents hereby irrevocably waives any right it may have to a trial
 by jury in respect of any claim based upon or arising out of this Agreement or the transactions
 contemplated hereby or thereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) *Titles and Subtitles*. The titles
 of the sections and subsections of this Agreement are for convenience and reference only
 and are not to be considered in construing this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) *Entire Agreement*. Other than the
 terms set forth in each Agency Transaction Notice delivered hereunder, this Agreement embodies
 the entire agreement and understanding between the parties hereto and supersedes all prior
 agreements and understandings relating to the subject matter hereof. This Agreement may not
 be amended or otherwise modified or any provision hereof waived except by an instrument in
 writing signed by the Agents and the Company. Notwithstanding the foregoing, any party to
 this Agreement may update its list of representatives on Schedule 1 or their contact information
 by notice to the other parties to this Agreement given in the manner provided for by this
 Agreement.

[Signature page follows]

Please confirm that the foregoing correctly sets forth the agreement between the Company and the Agents.

Very truly yours,

---

| | | |
|:---|:---|:---|
| **TITAN MINING CORPORATION** | **TITAN MINING CORPORATION** | **TITAN MINING CORPORATION** |
| By: | *(Signed) "Rita Adiani"* | *(Signed) "Rita Adiani"* |
|  | Name: | Rita Adiani |
|  | Title: | President and Chief Executive Officer |

---

Confirmed as of the date first above mentioned:

---

| | | |
|:---|:---|:---|
| <br> **BMO NESBITT BURNS INC.** | <br> **BMO NESBITT BURNS INC.** | <br> **BMO NESBITT BURNS INC.** |
| By: | *(Signed) "Carter Hohmann"* | *(Signed) "Carter Hohmann"* |
|  | Name: | Carter Hohmann |
|  | Title: | Managing Director |
| **BMO CAPITAL MARKETS CORP.** | **BMO CAPITAL MARKETS CORP.** | **BMO CAPITAL MARKETS CORP.** |
| By: | (Signed) "Brad Pavelka" | (Signed) "Brad Pavelka" |
|  | Name: | Brad Pavelka<br>|
|  | Title: | Managing Director |
| **CANTOR FITZGERALD CANADA CORPORATION** | **CANTOR FITZGERALD CANADA CORPORATION** | **CANTOR FITZGERALD CANADA CORPORATION** |
| By: | (Signed) "Elan Shevel" | (Signed) "Elan Shevel" |
|  | Name: | Elan Shevel<br>|
|  | Title: | Chief Compliance Officer |
| **CANTOR FITZGERALD & CO.** | **CANTOR FITZGERALD & CO.** | **CANTOR FITZGERALD & CO.** |
| By: | (Signed) "Sameer Vasudev" | (Signed) "Sameer Vasudev" |
|  | Name: | Sameer Vasudev<br>|
|  | Title: | Managing Director |
| **H.C. WAINWRIGHT & CO., LLC** | **H.C. WAINWRIGHT & CO., LLC** | **H.C. WAINWRIGHT & CO., LLC** |
| By: | (Signed) "Edward D. Silvera" | (Signed) "Edward D. Silvera" |
|  | Name: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Edward D. Silvera<br>|
|  | Title: | Co-Chief Executive Officer |
| **MAXIM GROUP LLC** | **MAXIM GROUP LLC** | **MAXIM GROUP LLC** |
| By: | (Signed) Larry Glassberg | (Signed) Larry Glassberg |
|  | Name: | Larry Glassberg<br>|
|  | Title: | Co-Head of Investment Banking |

---

Schedule 1

AUTHORIZED COMPANY REPRESENTATIVES

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Name and Office / Title | &nbsp;&nbsp;E-mail Address | &nbsp;&nbsp;Telephone Numbers |
| &nbsp;&nbsp;Rita Adiani, President and Chief Executive Officer | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;Purni Parikh, Senior Vice President, Corporate Affairs & Corporate Secretary | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;Kevin Hart, Chief Financial Officer | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;Tom Ladner, General Counsel | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |

---

\* Notices to be provided to at least one of the above Authorized Company Representatives.

AUTHORIZED AGENT REPRESENTATIVES

The Authorized Agent Representatives of BMO Nesbitt Burns Inc. are as follows

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Name and Office / Title | &nbsp;&nbsp;E-mail Address | &nbsp;&nbsp;Telephone Numbers |
| &nbsp;&nbsp;Carter Hohmann, Managing Director | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* |
| &nbsp;&nbsp;Franklin Wang, Vice President | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |

---

The Authorized Agent Representatives of BMO Capital Markets Corp. are as follows

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Name and Office / Title | &nbsp;&nbsp;E-mail Address | &nbsp;&nbsp;Telephone Numbers |
| &nbsp;&nbsp;Brad Pavelka, Managing Director | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;Eli Rossman, Associate | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* |
| &nbsp;&nbsp;EunSu Chang, Senior Counsel | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |

---

The Authorized Agent Representatives of Cantor Fitzgerald Canada Corporation are as follows

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Name and Office / Title | &nbsp;&nbsp;E-mail Address | &nbsp;&nbsp;Telephone Numbers |
| &nbsp;&nbsp;Elan Shevel, Chief Compliance Officer | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* |
| &nbsp;&nbsp;Jackson Hughes, Associate | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |

---

The Authorized Agent Representatives of Cantor Fitzgerald & Co. are as follows

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Name and Office / Title | &nbsp;&nbsp;E-mail Address | &nbsp;&nbsp;Telephone Numbers |
| &nbsp;&nbsp;Sameer Vasudev, Managing Director | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* |
| &nbsp;&nbsp;Johnathan Sargent, VP Investment Banking Legal and Assistant General Counsel | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |

---

The Authorized Agent Representatives of H.C. Wainwright & Co., LLC. are as follows

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Name and Office / Title | &nbsp;&nbsp;E-mail Address | &nbsp;&nbsp;Telephone Numbers |
| &nbsp;&nbsp;Craig Schwabe, Managing Director | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
| &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* |
| &nbsp;&nbsp;Charles Worthman, Managing Director | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |
|  | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |  |

---

The Authorized Agent Representatives of Maxim Group are as follows

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Name and Office / Title | &nbsp;&nbsp;E-mail Address | &nbsp;&nbsp;Telephone Numbers |
| &nbsp;&nbsp;James Siegel, General Counsel | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |  |
| &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* | &nbsp;&nbsp;*With a copy to :* |
| &nbsp;&nbsp;Larry Glassberg, Co-Head of Investment Banking | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] | &nbsp;&nbsp;[REDACTED - PERSONAL INFORMATION] |

---

Schedule 2

MATERIAL SUBSIDIARIES

1100951 B.C. Ltd.

Titan Mining (US) Corporation

Balmat Holding Corp.

Empire State Mines, LLC

Schedule 3

ISSUER FREE WRITING PROSPECTUSES

None.

EXHIBIT A

[Company Letterhead]

[ ], 20[___]

[BMO Nesbitt Burns Inc.]

[885 West Georgia Street, Suite 1700]

[Vancouver, British Columbia V6C 3E8]

VIA EMAIL

**<u>TRANSACTION NOTICE</u>**

Ladies and Gentlemen:

The purpose of this Transaction Notice is to propose certain terms of the Agency Transaction entered into with [the Canadian Agent / U.S. Agent] under, and pursuant to, that certain Equity Distribution Agreement between the Company and the Agents, dated [_____________] 1, 20[__] (the "**Agreement**"). Please indicate your acceptance of the proposed terms below. Upon acceptance, the particular Agency Transaction to which this Transaction Notice relates shall supplement, form a part of, and be subject to, the Agreement. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Agreement.

The terms of the particular Agency Transaction to which this Transaction Notice relates are as follows:

---

| | |
|:---|:---|
| <br> Trading Day(s) on which Shares may be Sold: | [________], 20[__], [________], 20[__],[________] … 20[__], |
| Maximum [Number]/[Value] of Shares to be Sold in the Aggregate: | [________] |
| Maximum [Number]/[Value] of Shares to be Sold on each Trading Day: | [________] |
| Stock exchange: | [________] |
| Floor Price: | [USD / CAD] [___.___] |

---

[Remainder of Page Intentionally Blank]

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **TITAN MINING CORPORATION** | **TITAN MINING CORPORATION** |
|  | Name:<br>|
|  | Title: |

---

---

| | |
|:---|:---|
| [BMO NESBITT BURNS INC.] | [BMO NESBITT BURNS INC.] |
| By: |  |
|  | Name: |
|  | Title: |

---

EXHIBIT B

Form of Opinion of<br> <u>Canadian Counsel to the Company</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Company is a corporation existing under the Business Corporations Act (British Columbia) and has the requisite corporate capacity and power to own its assets and to conduct its business as contemplated in the Prospectuses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The authorized share capital of the Company consists of an unlimited number of Common Shares. As of the date hereof, [●] Common Shares and nil Preferred Shares were issued and outstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The attributes of the Common Shares conform in all material respects with the description thereof in the Prospectuses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. [●] has been appointed as the transfer agent and registrar for the Common Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Shares have been duly authorized and validly allotted and reserved for issuance, and when issued in accordance with the terms of the Equity Distribution Agreement at the Settlement Date, upon receipt by the Company of the consideration therefor, will be issued as fully paid and non-assessable Common Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. The Shares have been conditionally approved for listing on the TSX subject only to satisfaction by the Company of customary post-closing conditions imposed by the TSX in similar circumstances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. The Company is a "reporting issuer", or its equivalent, in each of the Canadian Qualifying Jurisdictions and it is not listed as in default of any requirement of the securities laws in any of the Canadian Qualifying Jurisdictions in those jurisdictions where such lists are maintained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. The Company has the necessary corporate power and capacity to certify and file the Canadian Prospectus Supplement and all necessary corporate action has been taken by the Company to authorize the certification by it of the Canadian Prospectus Supplement and the filing thereof, as the case may be, in each of the provinces of Canada and in accordance with applicable Canadian Securities Laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. The Company has the corporate power to enter into and deliver the Equity Distribution Agreement and to perform its obligations thereunder and to carry out the transactions contemplated thereby, and the Equity Distribution Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable against the Company in accordance with its terms, subject to customary qualifications for enforceability opinions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. All necessary corporate action has been taken by the Company to authorize the execution and delivery by it of the Equity Distribution Agreement and the performance of its obligations thereunder and to authorize the issuance, sale and delivery of the Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. The execution and delivery by the Company of, and the performance by the Company of its obligations under, the Equity Distribution Agreement will not result in a breach or default of any provisions of (i) the articles or notice of articles of the Company or (ii) any applicable Canadian Securities Laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. Except such as have been made or obtained under applicable Canadian Securities Laws and filings after the date hereof by the Company required under applicable Canadian Securities Laws, the rules and policies of the TSX and any undertaking to a securities regulatory authority, and except to the extent that exemptions or waivers therefrom have been obtained from applicable securities regulatory authorities in Canada, no consent, approval, authorization or order of or filing, registration or qualification with any court, governmental agency or body or regulatory authority in Canada is required, for the execution, delivery and performance by the Company of this Equity Distribution Agreement or the consummation by the Company of the transactions contemplated therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. All necessary documents have been filed, all necessary proceedings have been taken and all legal requirements have been fulfilled as required under the laws of each of the Canadian Qualifying Jurisdictions in order to qualify the distribution of the Shares to the public in each of such Canadian Qualifying Jurisdictions by or through investment dealers and brokers duly registered under Canadian Securities Laws of such Canadian Qualifying Jurisdictions who have complied with the relevant provisions of such laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. The statements in the Canadian Prospectus Supplement under the captions "Certain Canadian Federal Income Tax Consideration" and "Eligibility for Investment" in so far as they purport to describe the provisions of the laws referred to therein, subject to specific assumptions, limitations and qualifications stated or referred to therein and applicable thereto, are accurate summaries of the matters discussed therein